@NP	Lamina Propria and Olfactory Bulb Ensheathing Cells	1
@NP	Differential Integration and Migration	61
@NP	Differential Axon Sprouting in the Lesioned Spinal Cord Miranda W.	112
@NP	Differential Axon Sprouting	112
@NP	the Lesioned Spinal Cord Miranda W.	143
@NP	Richter ,1 Patrick A.	180
@NP	Richter ,1	180
@NP	Patrick	190
@NP	A.	198
@NP	Fletcher ,1 Jie Liu ,2 Wolfram Tetzlaff ,2 and A.	201
@NP	Fletcher ,1 Jie Liu	201
@NP	,2 Wolfram Tetzlaff ,2 and A.	219
@NP	,2 Wolfram Tetzlaff ,2	219
@NP	A.	245
@NP	Jane Roskams1 1Department	248
@NP	Zoology and 2International Collaboration on Repair Discoveries	277
@NP	Zoology and 2International Collaboration	277
@NP	Repair Discoveries	321
@NP	University of British Columbia , Vancouver , British Columbia	341
@NP	University	341
@NP	British Columbia , Vancouver , British Columbia	355
@NP	Canada V5Z 4H4	402
@NP	OB OEC	469
@NP	significant promise in rat models of spinal cord injury	500
@NP	significant promise	500
@NP	rat models of spinal cord injury	523
@NP	rat models	523
@NP	spinal cord injury	537
@NP	the use	567
@NP	lamina propria-derived -LRB- peripheral -RRB- olfactory ensheathing cells	578
@NP	lamina	578
@NP	peripheral	602
@NP	LP OECs	643
@NP	both experimental and clinical trials	655
@NP	experimental	660
@NP	clinical trials	677
@NP	a common embryonic precursor	716
@NP	both sources of OECs	746
@NP	sources of OECs	751
@NP	sources	751
@NP	OECs	762
@NP	different nervous system compartments	777
@NP	their ability to promote regeneration and efficacy after transplantation	832
@NP	regeneration and efficacy	857
@NP	transplantation	889
@NP	both their source and mode of transplantation	929
@NP	their source	934
@NP	mode of transplantation	951
@NP	mode	951
@NP	transplantation	959
@NP	we	982
@NP	green fluorescent protein-expressing LP and OB OECs	999
@NP	green fluorescent protein-expressing LP	999
@NP	OB OECs	1043
@NP	their biological differences	1060
@NP	them	1116
@NP	rostral and caudal	1153
@NP	a dorsolateral funiculus crush	1175
@NP	LP and OB OECs	1207
@NP	multiple morphological and antigenic similarities	1230
@NP	transplantation	1301
@NP	they	1318
@NP	lesion and cavity formation	1338
@NP	angiogenesis , endogenous Schwann cell infiltration , and axonal sprouting	1378
@NP	angiogenesis	1378
@NP	endogenous Schwann cell infiltration	1392
@NP	axonal sprouting	1434
@NP	axonal	1434
@NP	an increased mitotic rate and migratory ability of LP OECs	1461
@NP	an increased mitotic rate	1461
@NP	migratory ability of LP OECs	1491
@NP	migratory ability	1491
@NP	LP OECs	1512
@NP	their superior ability	1554
@NP	the spinal cord	1595
@NP	cavity formation and lesion size	1619
@NP	cavity formation	1619
@NP	lesion size	1640
@NP	outgrowth of axonal subpopulations compared with OB OECs	1682
@NP	outgrowth	1682
@NP	axonal subpopulations compared with OB OECs	1695
@NP	axonal subpopulations	1695
@NP	OB OECs	1731
@NP	An undesired behavior -LRB- autotomy -RRB-	1740
@NP	An undesired behavior	1740
@NP	autotomy	1763
@NP	LP OEC	1808
@NP	OB OEC , transplantation	1821
@NP	OB OEC	1821
@NP	transplantation	1829
@NP	These results	1846
@NP	LP and OB OECs	1873
@NP	intrinsic biological differences	1896
@NP	transplantation into the lesioned CNS	1941
@NP	transplantation	1941
@NP	the lesioned CNS	1962
@NP	differences in postlesion spinal cord neuropathology	1990
@NP	differences	1990
@NP	postlesion spinal cord neuropathology	2005
@NP	anatomical and behavioral regeneration outcomes	2047
@NP	direct versus rostrocaudal transplantation	2123
@NP	direct	2123
@NP	rostrocaudal transplantation	2137
@NP	Introduction The abortive regeneration of CNS neurons	2168
@NP	Introduction The abortive regeneration	2168
@NP	Introduction	2168
@NP	The abortive regeneration	2181
@NP	CNS neurons	2210
@NP	stark contrast	2228
@NP	the renewal capacity	2246
@NP	the olfactory system -LRB- Graziadei et al. , 1978 , 1979 -RRB-	2270
@NP	the olfactory system	2270
@NP	Graziadei	2292
@NP	et al. , 1978 , 1979	2302
@NP	et al.	2302
@NP	1978	2310
@NP	1979	2316
@NP	Reconstitution of the olfactory neuraxis	2323
@NP	Reconstitution	2323
@NP	the olfactory neuraxis	2341
@NP	central axotomy -LRB- Zigova et al. , 1992 -RRB-	2385
@NP	central axotomy	2385
@NP	Zigova	2402
@NP	et al. , 1992	2409
@NP	et al.	2409
@NP	1992	2417
@NP	This axonal growth within the CNS	2424
@NP	This axonal growth	2424
@NP	the CNS	2450
@NP	olfactory ensheathing cells -LRB- OECs -RRB-	2491
@NP	olfactory ensheathing cells	2491
@NP	OECs	2520
@NP	resident	2527
@NP	the peripheral and central olfactory neuraxis -LRB- Doucette , 1990 -RRB-	2539
@NP	the peripheral and central olfactory neuraxis	2539
@NP	Doucette , 1990	2586
@NP	Doucette	2586
@NP	1990	2596
@NP	Lamina propria-derived	3129
@NP	LP	3153
@NP	OECs	3157
@NP	their ability	3197
@NP	regeneration	3222
@NP	lesion -LRB- Lu et al. , 2001 , 2002 ; Ramer et al. , 2004a , b -RRB-	3241
@NP	lesion	3241
@NP	Lu et al. , 2001 , 2002 ; Ramer et al. , 2004a , b	3249
@NP	Lu et al.	3249
@NP	Lu	3249
@NP	et al.	3252
@NP	2001 , 2002 ; Ramer et al.	3260
@NP	2001 , 2002	3260
@NP	2001	3260
@NP	2002	3266
@NP	Ramer et al.	3272
@NP	Ramer	3272
@NP	et al.	3278
@NP	2004a , b	3286
@NP	2004a	3286
@NP	b	3292
@NP	the ongoing clinical use	3304
@NP	LP tissue	3332
@NP	spinal cord injury -LRB- SCI -RRB- treatment	3345
@NP	spinal cord injury -LRB- SCI -RRB-	3345
@NP	spinal cord injury	3345
@NP	SCI	3365
@NP	Senior , 2002 ; Huang et al. , 2003	3381
@NP	Senior	3381
@NP	2002 ; Huang et al.	3389
@NP	2002	3389
@NP	Huang et al.	3395
@NP	Huang	3395
@NP	et al.	3401
@NP	2003	3409
@NP	LP and OB OECs	3416
@NP	a common progenitor	3445
@NP	the olfactory mucosa -LRB- Carter et al. , 2004 -RRB- , ensheath	3468
@NP	the olfactory mucosa -LRB- Carter et al. , 2004 -RRB-	3468
@NP	the olfactory mucosa	3468
@NP	Carter	3490
@NP	et al. , 2004	3497
@NP	et al.	3497
@NP	2004	3505
@NP	ensheath	3512
@NP	the growth of olfactory receptor neuron axons	3533
@NP	the growth	3533
@NP	olfactory receptor neuron axons	3547
@NP	they	3582
@NP	the olfactory epithelium	3592
@NP	theOB -LRB- Williams et al. , 2004 -RRB-	3635
@NP	theOB	3635
@NP	Williams	3641
@NP	et al. , 2004	3650
@NP	et al.	3650
@NP	2004	3658
@NP	LP OECs	3668
@NP	the nerve fiber layer of the OB	3682
@NP	the nerve fiber layer	3682
@NP	the OB	3707
@NP	they	3715
@NP	OB OECs	3739
@NP	they	3754
@NP	astrocytes -LRB- Au et al. , 2002 -RRB-	3774
@NP	astrocytes	3774
@NP	Au	3786
@NP	et al. , 2002	3789
@NP	et al.	3789
@NP	2002	3797
@NP	LP and OB OECs	3819
@NP	similarities in morphology and function in vitro	3842
@NP	similarities	3842
@NP	morphology and function	3858
@NP	Au and Roskams , 2003 ; Jani and Raisman , 2004	3892
@NP	Au and Roskams	3892
@NP	2003 ; Jani and Raisman	3908
@NP	2003	3908
@NP	Jani and Raisman	3914
@NP	2004	3932
@NP	subtle differences	3939
@NP	behavior	3973
@NP	their distinct roles in the olfactory neuraxis	3983
@NP	their distinct roles	3983
@NP	the olfactory neuraxis	4007
@NP	their different maturational states	4035
@NP	they	4079
@NP	different properties	4096
@NP	SCI	4141
@NP	Groups	4146
@NP	varying regeneration outcomes	4175
@NP	dorsal rhizotomy and transplantation ofOBversus LP OECs	4211
@NP	Ramon-Cueto and Nieto-Sampedro	4268
@NP	1994 ; Ramer et al. , 2004a ; Riddell et al.	4300
@NP	1994	4300
@NP	Ramer et al. , 2004a ; Riddell et al.	4306
@NP	Ramer	4306
@NP	et al. , 2004a ; Riddell et al.	4312
@NP	et al. , 2004a	4312
@NP	et al.	4312
@NP	2004a	4320
@NP	Riddell et al.	4327
@NP	Riddell	4327
@NP	et al.	4335
@NP	2004	4343
@NP	these cases	4353
@NP	the mode	4366
@NP	transplantation and proximity of transplanted cells to the lesion site	4378
@NP	transplantation and proximity	4378
@NP	transplanted cells to the lesion site	4411
@NP	transplanted cells	4411
@NP	the lesion site	4433
@NP	integration and long-term cell survival of transplanted cells	4465
@NP	integration and long-term cell survival	4465
@NP	transplanted cells	4508
@NP	these differences	4542
@NP	different OEC sources , methods of transplantation , and assessment measures	4575
@NP	different OEC sources	4575
@NP	methods of transplantation	4598
@NP	methods	4598
@NP	transplantation	4609
@NP	assessment measures	4630
@NP	it	4651
@NP	the regeneration-promoting abilities of LP and OB OECs	4686
@NP	the regeneration-promoting abilities	4686
@NP	LP and OB OECs	4726
@NP	the same experiment	4748
@NP	we	4775
@NP	transgenic enhanced green fluorescent protein -LRB- eGFP -RRB- - expressing OECs	4792
@NP	transgenic enhanced green fluorescent protein -LRB- eGFP -RRB-	4792
@NP	transgenic enhanced green fluorescent protein	4792
@NP	eGFP	4839
@NP	OECs	4856
@NP	the lamina propria	4866
@NP	the nerve fiber layer of the same mice	4894
@NP	the nerve fiber layer	4894
@NP	the same mice	4919
@NP	their expansion and phenotype	4953
@NP	we	4993
@NP	them	5017
@NP	a dorsolateral funiculus crush	5054
@NP	Differences examined	5086
@NP	Differences	5086
@NP	interactions	5115
@NP	host glia	5133
@NP	their ability to promote directional angiogenesis	5144
@NP	directional angiogenesis	5169
@NP	their migratory properties within the spinal cord	5199
@NP	their migratory properties	5199
@NP	the spinal cord	5233
@NP	we	5263
@NP	differences between LP and OB OECtreated animals	5307
@NP	differences	5307
@NP	LP and OB OECtreated animals	5327
@NP	differences	5373
@NP	autotomy resulting from transplantation of these two cell populations	5388
@NP	autotomy	5388
@NP	transplantation of these two cell populations	5412
@NP	transplantation	5412
@NP	these two cell populations	5431
@NP	Materials and Methods Cell preparation and purification .	5459
@NP	Materials and Methods	5459
@NP	Materials	5459
@NP	Methods	5473
@NP	Cell preparation and purification	5481
@NP	Cell preparation	5481
@NP	purification	5502
@NP	LP OEC cell culture	5516
@NP	GFP + LP OECs	5537
@NP	GFP	5537
@NP	LP OECs	5542
@NP	the olfactory mucosa of postnatal day	5570
@NP	the olfactory mucosa	5570
@NP	postnatal day	5594
@NP	5 -LRB- P5 -RRB- transgenic mice	5608
@NP	5 -LRB- P5 -RRB-	5608
@NP	transgenic mice	5615
@NP	eGFP -LSB- GFP-U-NAGY	5647
@NP	Andreas Nagy	5678
@NP	University	5692
@NP	Toronto , Toronto , Ontario , Canada	5706
@NP	kind gift from Frank Jirik , University of Calgary , Calgary , Alberta , Canada	5741
@NP	kind gift from Frank Jirik	5741
@NP	kind gift	5741
@NP	Frank Jirik	5756
@NP	University of Calgary	5769
@NP	University	5769
@NP	Calgary	5783
@NP	Calgary	5792
@NP	Alberta , Canada	5801
@NP	Alberta	5801
@NP	Canada	5810
@NP	the betta-actin promoter	5834
@NP	the cytomegalovirus enhancer -LRB- Au and Roskams , 2003 -RRB-	5873
@NP	the cytomegalovirus enhancer	5873
@NP	Au and Roskams	5903
@NP	2003	5919
@NP	The entire olfactory mucosa , including turbinates and septum ,	5926
@NP	The entire olfactory mucosa	5926
@NP	turbinates and septum	5965
@NP	turbinates	5965
@NP	septum	5980
@NP	8 -- 10 pups	6007
@NP	8	6007
@NP	10 pups	6009
@NP	0.6 mg/ml collagenase D -LRB- Roche Products , Indianapolis , IN -RRB-	6061
@NP	0.6 mg/ml collagenase D	6061
@NP	Roche Products , Indianapolis	6086
@NP	Roche Products	6086
@NP	Indianapolis	6102
@NP	3 U/ml dispase I	6121
@NP	Roche Products	6139
@NP	15 µg/ml hyaluronidase -LRB- Sigma , St.	6156
@NP	15 µg/ml hyaluronidase	6156
@NP	Sigma	6180
@NP	St.	6187
@NP	Louis , MO -RRB-	6191
@NP	Louis	6191
@NP	0.5 mg/ml bovine serum albumin -LRB- MP Biomedicals , Irvine , CA -RRB-	6203
@NP	0.5 mg/ml bovine serum albumin	6203
@NP	MP Biomedicals	6235
@NP	Irvine	6251
@NP	CA	6259
@NP	100 U/ml DNase I -LRB- Sigma -RRB-	6268
@NP	100 U/ml DNase	6268
@NP	I -LRB- Sigma -RRB-	6283
@NP	I	6283
@NP	Sigma	6286
@NP	1 h at 37 °C	6297
@NP	1 h	6297
@NP	37 °C	6304
@NP	centrifugation and plating	6317
@NP	Initial plating in MEM	6345
@NP	Initial plating	6345
@NP	MEM	6364
@NP	D-valine , 10 % fetal bovine serum -LRB- FBS -RRB-	6368
@NP	D-valine	6368
@NP	10 % fetal bovine serum -LRB- FBS -RRB-	6378
@NP	10 % fetal bovine serum	6378
@NP	FBS	6402
@NP	100 U/ml penicillin/streptomycin -LRB- P/S -RRB-	6412
@NP	100 U/ml penicillin/streptomycin	6412
@NP	P/S	6446
@NP	4	6464
@NP	5 d	6466
@NP	purification using anti-Thy1.1-mediated complement lysis	6479
@NP	purification	6479
@NP	anti-Thy1.1-mediated complement lysis	6498
@NP	fibroblasts -LRB- Au and Roskams , 2003 -RRB-	6585
@NP	fibroblasts	6585
@NP	Au and Roskams	6598
@NP	2003	6614
@NP	Cells	6621
@NP	DMEM/F -12 , 10 % FBS , and 100 U/ml P/S	6644
@NP	DMEM/F -12	6644
@NP	10 % FBS	6655
@NP	100 U/ml P/S	6668
@NP	an additional 4	6705
@NP	6 d , when they were again subjected to Thy1.1-mediated complement lysis	6721
@NP	6 d	6721
@NP	they	6731
@NP	Thy1.1-mediated complement lysis	6760
@NP	LP OECs	6794
@NP	a density of 5600 cells/cm 2	6817
@NP	a density	6817
@NP	5600 cells/cm 2	6830
@NP	5600 cells/cm	6830
@NP	2	6844
@NP	T75 flasks for transplantation	6851
@NP	T75 flasks	6851
@NP	transplantation	6866
@NP	The time from dissection to transplantation	6883
@NP	The time	6883
@NP	dissection to transplantation	6897
@NP	dissection	6897
@NP	transplantation	6911
@NP	14	6939
@NP	16 d in vitro	6945
@NP	16 d	6945
@NP	DIV	6960
@NP	OB OEC cell culture	6966
@NP	the same litter of P5 eGFP transgenic mice	6992
@NP	the same litter	6992
@NP	P5 eGFP transgenic mice	7011
@NP	OB OECs	7036
@NP	the head	7083
@NP	the meningeal covering of the olfactory bulb	7102
@NP	the meningeal covering	7102
@NP	the olfactory bulb	7128
@NP	a scalpel	7154
@NP	partition the rostralmost quarter of the olfactory bulb	7167
@NP	partition	7167
@NP	the rostralmost quarter	7177
@NP	the olfactory bulb	7204
@NP	the portion of the nerve fiber layer	7239
@NP	the portion	7239
@NP	the nerve fiber layer	7254
@NP	the cribriform plate	7284
@NP	Nerve fiber layers	7306
@NP	Ramon-Cueto	7371
@NP	et al. -LRB- 1998 -RRB-	7383
@NP	et al.	7383
@NP	1998	7391
@NP	digestion by 0.1 % trypsin for 15 min at 37 °C	7407
@NP	digestion	7407
@NP	0.1 % trypsin for 15 min at 37 °C	7420
@NP	0.1 % trypsin	7420
@NP	15 min at 37 °C	7437
@NP	15 min	7437
@NP	37 °C	7447
@NP	dissociation	7468
@NP	multiple passes	7484
@NP	fire-polished pipettes	7508
@NP	the cells	7536
@NP	poly-L-lysine -LRB- PLL -RRB-	7563
@NP	poly-L-lysine	7563
@NP	PLL	7578
@NP	50 µg/ml in 15 mM sodium borate buffer ; Sigma	7584
@NP	50 µg/ml	7584
@NP	15 mM sodium borate buffer ; Sigma	7596
@NP	15 mM sodium borate buffer	7596
@NP	15 mM	7596
@NP	sodium borate buffer	7602
@NP	Sigma	7624
@NP	pretreated flasks -LRB- 1 h at room temperature -RRB-	7631
@NP	pretreated flasks	7631
@NP	1 h at room temperature	7650
@NP	1 h	7650
@NP	room temperature	7657
@NP	DMEM/F -12	7686
@NP	2 mM L-glutamine , 10 % FBS , 50 µg/ml gentamycin , and 100 U/ml P/S	7715
@NP	2 mM L-glutamine	7715
@NP	10 % FBS	7733
@NP	50 µg/ml gentamycin	7742
@NP	100 U/ml P/S	7767
@NP	5 -- 6 DIV , when cells had grown to -80 % confluency	7787
@NP	5	7787
@NP	6 DIV , when cells had grown to -80 % confluency	7789
@NP	6 DIV	7789
@NP	cells	7801
@NP	-80 % confluency	7820
@NP	-80 %	7820
@NP	confluency	7825
@NP	OB OECs	7837
@NP	immunopanning	7862
@NP	Detached cells	7877
@NP	DMEM/F -12	7910
@NP	10 % FBS	7925
@NP	500,000 cells	7938
@NP	each 96mmPetri dish	7969
@NP	biotinylated goat-anti rabbit	8010
@NP	IgG antibody -LRB- 3 µg/ml , 12 h ,	8040
@NP	IgG antibody	8040
@NP	3 µg/ml	8054
@NP	4 °C ; Vector Laboratories	8069
@NP	4	8069
@NP	°C	8070
@NP	Vector Laboratories	8074
@NP	Burlingame , CA -RRB-	8095
@NP	Burlingame	8095
@NP	-LRB- 2 -RRB- rabbit anti-low-affinity nerve growth factor receptor	8115
@NP	rabbit anti-low-affinity nerve	8119
@NP	factor receptor	8157
@NP	1:500	8174
@NP	1 h	8181
@NP	p75 ; Chemicon , Temecula ,	8206
@NP	p75	8206
@NP	Chemicon	8211
@NP	Temecula	8221
@NP	CA	8231
@NP	Cells	8236
@NP	30 min at 37 °C	8261
@NP	30 min	8261
@NP	37 °C	8271
@NP	unbound cells	8277
@NP	cells	8324
@NP	a cell lifter	8350
@NP	The 30 min immunopanning incubation	8365
@NP	30 min	8369
@NP	it	8418
@NP	the greatest purity of OB OEC cultures	8430
@NP	the greatest purity	8430
@NP	OB OEC cultures	8453
@NP	an average of 92 % p75 - positive cells -LRB- n = 4 -RRB-	8475
@NP	an average	8475
@NP	92 % p75 - positive cells -LRB- n = 4 -RRB-	8489
@NP	92 % p75	8489
@NP	positive cells	8498
@NP	n	8514
@NP	4	8516
@NP	OBOECs	8519
@NP	a density of 6500 cells/cm 2	8576
@NP	a density	8576
@NP	6500 cells/cm 2	8589
@NP	6500 cells/cm	8589
@NP	2	8603
@NP	T75 flasks for transplantation	8610
@NP	T75 flasks	8610
@NP	transplantation	8625
@NP	The time from dissection to transplantation	8642
@NP	The time	8642
@NP	dissection to transplantation	8656
@NP	dissection	8656
@NP	transplantation	8670
@NP	between 14 and 16 DIV	8690
@NP	Cell harvest for transplantation .	8713
@NP	Cell harvest	8713
@NP	transplantation	8730
@NP	transplantation	8754
@NP	the cells from one T75 flask of LP or OB OECs	8771
@NP	the cells	8771
@NP	one T75 flask of LP or OB OECs	8786
@NP	one T75 flask	8786
@NP	LP or OB OECs	8803
@NP	0.25 % trypsin/1 % EDTA	8837
@NP	0.25 %	8837
@NP	trypsin/1 %	8843
@NP	PBS	8883
@NP	resuspension at a concentration of 50,000 -- 60,000 cells/µl in DMEM/F -12	8891
@NP	resuspension at a concentration of 50,000	8891
@NP	resuspension	8891
@NP	a concentration of 50,000	8907
@NP	a concentration	8907
@NP	50,000	8926
@NP	60,000 cells/µl in DMEM/F -12	8933
@NP	60,000 cells/µl	8933
@NP	DMEM/F -12	8952
@NP	These cells	8963
@NP	two recipient rats	9010
@NP	every rat	9044
@NP	freshly harvested cells	9063
@NP	Immunocytochemistry : assessment of cell purity .	9088
@NP	Immunocytochemistry	9088
@NP	assessment of cell purity	9109
@NP	assessment	9109
@NP	cell purity	9123
@NP	LP OECs .	9136
@NP	cell purity	9155
@NP	cells	9186
@NP	typical morphology and phenotype	9200
@NP	transplantation	9240
@NP	GFP + LP OECs	9257
@NP	GFP	9257
@NP	LP OECs	9262
@NP	glass slides	9287
@NP	the second subculture	9306
@NP	4 % paraformaldehyde -LRB- PFA -RRB-	9341
@NP	4 % paraformaldehyde	9341
@NP	PFA	9362
@NP	2 DIV	9373
@NP	Purity of the culture	9380
@NP	Purity	9380
@NP	the culture	9390
@NP	the following primary antibodies incubated overnight at 4 °C	9421
@NP	the following primary antibodies	9421
@NP	4 °C	9477
@NP	rabbit anti-p75 -LRB- 1:1000 ; Chemicon -RRB-	9482
@NP	rabbit anti-p75	9482
@NP	1:1000 ; Chemicon	9499
@NP	1:1000	9499
@NP	Chemicon	9507
@NP	anti-mouse S100betta -LRB- 1:1000 ; Sigma -RRB-	9518
@NP	anti-mouse S100betta	9518
@NP	1:1000 ; Sigma	9540
@NP	1:1000	9540
@NP	Sigma	9548
@NP	anti-glial fibrillary acidic protein -LRB- GFAP -RRB-	9560
@NP	anti-glial fibrillary acidic protein	9560
@NP	GFAP	9598
@NP	1:750 ; DakoCytomation , Glostrup , Denmark	9605
@NP	1:750	9605
@NP	DakoCytomation , Glostrup , Denmark	9612
@NP	Slides	9648
@NP	1 h	9679
@NP	room temperature with Alexa 594 goat secondary antibodies	9686
@NP	room temperature with Alexa 594 goat	9686
@NP	room temperature	9686
@NP	Alexa 594 goat	9708
@NP	1:100 ; Jackson ImmunoResearch , Mississauga , Ontario , Canada	9745
@NP	1:100	9745
@NP	Jackson ImmunoResearch , Mississauga , Ontario , Canada	9752
@NP	2 % goat serum	9809
@NP	a 10 min incubation	9836
@NP	0.5 µg/ml 4-,6-diamidine-2-phenylindole dihydrochloride -LRB- DAPI -RRB-	9859
@NP	0.5 µg/ml 4-,6-diamidine-2-phenylindole dihydrochloride	9859
@NP	0.5 µg/ml	9859
@NP	DAPI	9916
@NP	Boehringer Mannheim	9923
@NP	Mannheim	9944
@NP	Germany	9954
@NP	Vectashield mounting media	9984
@NP	Vector Laboratories	10012
@NP	OB OECs .	10034
@NP	the optimal time and antibody concentrations for immunopanning	10067
@NP	the optimal time and antibody concentrations	10067
@NP	immunopanning	10116
@NP	OB OEC purity	10131
@NP	different panning conditions	10169
@NP	glass slides	10203
@NP	rabbit anti-p75 -LRB- 1:1000 ; Chemicon -RRB-	10250
@NP	rabbit anti-p75	10250
@NP	1:1000 ; Chemicon	10267
@NP	1:1000	10267
@NP	Chemicon	10275
@NP	secondary antibodies and DAPI	10297
@NP	secondary antibodies	10297
@NP	DAPI	10322
@NP	DAPI nuclei	10347
@NP	as well as p75 + cells to assess for the enrichment of p75 + cells	10373
@NP	p75	10384
@NP	cells to assess for the enrichment of p75 + cells	10389
@NP	the enrichment of p75 + cells	10409
@NP	the enrichment	10409
@NP	p75 + cells	10427
@NP	p75	10427
@NP	cells	10432
@NP	cell purification procedures	10456
@NP	allOBOECcell cultures	10486
@NP	the same slide generation	10531
@NP	second subculture and immunocytochemistry	10563
@NP	LP OECs	10628
@NP	In vitro migration assays .	10637
@NP	In vitro migration	10637
@NP	assays	10656
@NP	LP or OB OECs cultured for the same DIV	10664
@NP	LP or OB OECs	10664
@NP	the same DIV	10691
@NP	passage 2	10722
@NP	Boyden chambers	10748
@NP	PLL	10780
@NP	50µg/ml in borate buffer , 1 h at room temperature	10785
@NP	50µg/ml	10785
@NP	borate buffer , 1 h at room temperature	10796
@NP	borate buffer	10796
@NP	1 h at room temperature	10811
@NP	1 h	10811
@NP	room temperature	10818
@NP	laminin	10839
@NP	1 µg/ml in PBS , 1 h at 37 °C	10848
@NP	1 µg/ml	10848
@NP	PBS , 1 h at 37 °C	10859
@NP	PBS	10859
@NP	1 h at 37 °C	10864
@NP	1 h	10864
@NP	37 °C	10871
@NP	24-well plates	10880
@NP	a density of 5000 cells/well	10898
@NP	a density	10898
@NP	5000 cells/well	10911
@NP	The main well	10928
@NP	2.5 % FBS	10952
@NP	DMEM/F -12	10964
@NP	Cells	10975
@NP	20 h	10994
@NP	the top sides of experimental transwells	11000
@NP	the top sides	11000
@NP	experimental transwells	11017
@NP	both sides	11060
@NP	negative controls	11088
@NP	neither side	11111
@NP	positive controls	11140
@NP	Transwells	11159
@NP	0.1 % glutaraldehyde in 4 % PFA in PBS	11184
@NP	0.1 % glutaraldehyde	11184
@NP	4 % PFA in PBS	11207
@NP	4 % PFA	11207
@NP	PBS	11217
@NP	30 min at room temperature	11225
@NP	30 min	11225
@NP	room temperature	11235
@NP	Membranes	11253
@NP	DAPI	11286
@NP	glass slides	11305
@NP	Vectashield -LRB- Vector Laboratories -RRB-	11337
@NP	Vectashield	11337
@NP	Vector Laboratories	11350
@NP	5x images	11376
@NP	the entire membrane	11415
@NP	DAPI + nuclei	11436
@NP	DAPI	11436
@NP	nuclei	11442
@NP	migration values	11467
@NP	a percentage	11502
@NP	total cells	11518
@NP	positive membranes	11533
@NP	experimental	11553
@NP	negative counts	11572
@NP	the total cells on positive membranes	11599
@NP	the total cells	11599
@NP	positive membranes	11618
@NP	Spinal cord injury and cell transplantation .	11639
@NP	Spinal cord	11639
@NP	injury and cell transplantation	11651
@NP	Dorsolateral funiculus crush .	11684
@NP	Dorsolateral funiculus	11684
@NP	crush	11707
@NP	Animal procedures	11714
@NP	accordance	11750
@NP	the guidelines of the Canadian Council for Animal Care	11766
@NP	the guidelines	11766
@NP	the Canadian Council for Animal Care	11784
@NP	the Canadian Council	11784
@NP	Animal Care	11809
@NP	the Animal Care Committee of the University of British Columbia	11842
@NP	the Animal Care Committee	11842
@NP	the University of British Columbia	11871
@NP	the University	11871
@NP	British Columbia	11889
@NP	Forty-two adult male Sprague Dawley rats	11907
@NP	150	11949
@NP	200 g ; Charles River Laboratories , Wilmington , MA	11953
@NP	200 g	11953
@NP	Charles River Laboratories , Wilmington , MA	11960
@NP	Charles River Laboratories	11960
@NP	Wilmington , MA	11988
@NP	cyclosporine A -LRB- 10 mg * kg-1	12031
@NP	cyclosporine A -LRB- 10 mg	12031
@NP	cyclosporine A	12031
@NP	10 mg	12047
@NP	10	12047
@NP	mg	12050
@NP	kg-1	12055
@NP	d-1 , i.p. ; Novartis Pharmaceuticals , Mississauga , Ontario , Canada -RRB- 2 d	12062
@NP	d-1 , i.p. ; Novartis Pharmaceuticals , Mississauga , Ontario , Canada -RRB-	12062
@NP	d-1 , i.p.	12062
@NP	d-1	12062
@NP	Novartis Pharmaceuticals , Mississauga , Ontario , Canada	12073
@NP	Novartis Pharmaceuticals	12073
@NP	Mississauga , Ontario , Canada	12099
@NP	surgery and each day	12140
@NP	surgery	12140
@NP	each day	12152
@NP	the duration of the experiment	12165
@NP	the duration	12165
@NP	the experiment	12181
@NP	anaesthetization with xylazine/ketamine -LRB- 10 and 70 mg/kg , i.p. -RRB-	12203
@NP	anaesthetization	12203
@NP	xylazine/ketamine -LRB- 10 and 70 mg/kg , i.p. -RRB-	12225
@NP	xylazine/ketamine	12225
@NP	10 and 70 mg/kg , i.p.	12244
@NP	10 and 70 mg/kg	12244
@NP	10	12244
@NP	70 mg/kg	12251
@NP	a hemilaminectomy	12268
@NP	the left halves of the third and fourth cervical segments	12310
@NP	the left halves	12310
@NP	the third and fourth cervical segments	12329
@NP	The dura	12369
@NP	microscissors	12396
@NP	the spinal cord	12420
@NP	one prong of custom-designed fine surgical forceps	12441
@NP	one prong	12441
@NP	custom-designed fine surgical forceps	12454
@NP	the gray and white matter	12513
@NP	the other prong outside the dorsolateral funiculus	12545
@NP	the other prong	12545
@NP	the dorsolateral funiculus	12569
@NP	a depth of 1 mm	12600
@NP	a depth	12600
@NP	1 mm	12611
@NP	The forceps	12617
@NP	18	12650
@NP	20 s , crushing the dorsolateral funiculus	12653
@NP	20 s	12653
@NP	the dorsolateral funiculus	12668
@NP	Previous studies in our laboratory	12696
@NP	Previous studies	12696
@NP	our laboratory	12716
@NP	this injury	12751
@NP	all rubrospinal axons -LRB- Ramer et al. , 2004 -RRB-	12779
@NP	all rubrospinal axons	12779
@NP	Ramer	12802
@NP	et al. , 2004	12808
@NP	et al.	12808
@NP	2004	12816
@NP	Crush treatment	12823
@NP	animals	12868
@NP	cell transplantation and control groups	12895
@NP	crush	12941
@NP	Cell transplantation .	12948
@NP	Cell	12948
@NP	transplantation	12953
@NP	LP or OB OEC cell slurries in DMEM/F -12	12970
@NP	LP	12970
@NP	OB OEC cell slurries in DMEM/F -12	12976
@NP	OB OEC cell slurries	12976
@NP	DMEM/F -12	13000
@NP	a pulled glass pipette with a diameter of 20µm in a Hamilton syringe	13026
@NP	a pulled glass pipette	13026
@NP	a diameter of 20µm in a Hamilton syringe	13054
@NP	a diameter	13054
@NP	20µm in a Hamilton syringe	13068
@NP	20µm	13068
@NP	a Hamilton syringe	13076
@NP	OECs	13096
@NP	within the lesion	13147
@NP	site	13165
@NP	three injection points	13175
@NP	a depth of 0.7 , 1.0 , and 1.5 mm	13202
@NP	a depth	13202
@NP	0.7 , 1.0 , and 1.5 mm	13213
@NP	0.7	13213
@NP	1.0	13218
@NP	1.5 mm	13227
@NP	the cell suspension	13244
@NP	these three points	13280
@NP	1 mm	13307
@NP	rostral and caudal -LRB- R/C -RRB- to the lesion site at a depth of 0.6 and 1.2	13312
@NP	rostral and caudal -LRB- R/C -RRB-	13312
@NP	rostral and caudal	13312
@NP	R/C	13332
@NP	the lesion site	13340
@NP	a depth	13359
@NP	0.6 and 1.2	13370
@NP	mm	13382
@NP	the suspension	13395
@NP	four points	13426
@NP	supplemental Fig. 1 , available at www.jneurosci.org	13453
@NP	supplemental Fig. 1	13453
@NP	www.jneurosci.org	13487
@NP	supplemental material	13508
@NP	A total of 1.5 µl of cell slurry	13532
@NP	A total	13532
@NP	1.5 µl of cell slurry	13543
@NP	1.5 µl	13543
@NP	cell slurry	13553
@NP	a rate of 100 nl/min	13581
@NP	a rate	13581
@NP	100 nl/min	13591
@NP	each rat	13611
@NP	a total of 75,000 -- 90,000 cells	13629
@NP	a total of 75,000	13629
@NP	a total	13629
@NP	75,000	13640
@NP	90,000 cells	13648
@NP	Control animals	13662
@NP	the same volume of DMEM/F -12 injected at the same sites at the same rate	13687
@NP	the same volume	13687
@NP	DMEM/F -12 injected at the same sites at the same rate	13706
@NP	DMEM/F -12	13706
@NP	the same sites at the same rate	13728
@NP	the same sites	13728
@NP	the same rate	13746
@NP	The glass pipette	13761
@NP	place for 5 min	13791
@NP	place	13791
@NP	5 min	13801
@NP	each injection	13813
@NP	cells	13843
@NP	the spinal cord	13861
@NP	the syringe	13905
@NP	injection	13924
@NP	the pipette	13935
@NP	the muscle and skin	13975
@NP	interrupted sutures	14012
@NP	The 28 d survival groups	14033
@NP	direct LP OEC	14075
@NP	n = 5	14090
@NP	n	14090
@NP	5	14092
@NP	R/C LP OEC , n = 4	14095
@NP	R/C LP OEC	14095
@NP	n = 4	14107
@NP	n	14107
@NP	4	14111
@NP	direct OB OEC , n = 4	14114
@NP	direct OB OEC	14114
@NP	n = 4	14129
@NP	n	14129
@NP	4	14133
@NP	R/C OB OEC , n = 4	14136
@NP	R/C OB OEC	14136
@NP	n = 4	14148
@NP	n	14148
@NP	4	14152
@NP	direct control , n	14155
@NP	direct control	14155
@NP	n	14171
@NP	4	14175
@NP	R/C control	14182
@NP	n = 4	14195
@NP	n	14195
@NP	4	14199
@NP	The 24 h survival groups	14202
@NP	direct LP OEC , n = 3 ; R/C LP OEC , n = 5 ; R/C OB OEC , n	14244
@NP	direct LP OEC	14244
@NP	n = 3 ; R/C LP OEC , n = 5 ; R/C OB OEC , n	14259
@NP	n = 3	14259
@NP	n	14259
@NP	3	14261
@NP	R/C LP OEC , n = 5	14264
@NP	R/C LP OEC	14264
@NP	n = 5	14276
@NP	n	14276
@NP	5	14278
@NP	R/C OB OEC , n	14281
@NP	R/C OB OEC	14281
@NP	n	14293
@NP	4	14295
@NP	R/C control	14302
@NP	n = 5	14315
@NP	n	14315
@NP	5	14319
@NP	Immunohistochemistry .	14322
@NP	24 h or 28 d after SCI and transplantation	14347
@NP	24 h	14347
@NP	28 d after SCI and transplantation	14355
@NP	28 d	14355
@NP	SCI and transplantation	14366
@NP	SCI	14366
@NP	transplantation	14374
@NP	animals	14391
@NP	a lethal overdose of chloral hydrate -LRB- 100 mg/kg , i.p. -RRB-	14416
@NP	a lethal overdose	14416
@NP	chloral hydrate -LRB- 100 mg/kg , i.p. -RRB-	14437
@NP	chloral hydrate	14437
@NP	100 mg/kg , i.p.	14454
@NP	100 mg/kg	14454
@NP	PBS	14504
@NP	4 % PFA	14521
@NP	pH 7.4	14529
@NP	Cervical spinal cords and brain	14537
@NP	successive sucrose sinking in 12 , 18 , and 24 % sucrose in PBS	14604
@NP	successive sucrose sinking	14604
@NP	12 , 18 , and 24 % sucrose in PBS	14634
@NP	12	14634
@NP	18	14638
@NP	24 % sucrose in PBS	14646
@NP	24 % sucrose	14646
@NP	PBS	14661
@NP	24 h each	14669
@NP	24 h	14669
@NP	each	14674
@NP	freezing in Tissue-Tek	14692
@NP	freezing	14692
@NP	Tissue-Tek	14704
@NP	optimal cutting temperature compound	14715
@NP	Sakura	14753
@NP	Tokyo	14761
@NP	Japan	14768
@NP	isopentane	14778
@NP	dry ice	14794
@NP	Sections of spinal cord	14803
@NP	Sections	14803
@NP	spinal cord	14815
@NP	14 µm	14845
@NP	-20 °C	14865
@NP	Standard immunohistochemical procedures used for most detection	14872
@NP	Standard immunohistochemical procedures	14872
@NP	most detection	14921
@NP	sections	14953
@NP	the slide	14989
@NP	10 min	15014
@NP	postfixation	15034
@NP	4 % PFA for 10 min	15050
@NP	4 % PFA	15050
@NP	10 min	15061
@NP	30 min of permeabilization in 0.01 % Triton X-100	15069
@NP	30 min of permeabilization in 0.01 %	15069
@NP	30 min	15069
@NP	permeabilization in 0.01 %	15079
@NP	permeabilization	15079
@NP	0.01 %	15099
@NP	Triton X-100	15105
@NP	20 min block in 4 % normal goat serum in PBS	15119
@NP	20 min block	15119
@NP	4 % normal goat serum	15135
@NP	PBS	15159
@NP	incubation of primary antibody	15168
@NP	incubation	15168
@NP	primary antibody	15182
@NP	4 °C in 2 % serum	15212
@NP	4 °C	15212
@NP	2 % serum	15219
@NP	Secondary antibodies raised in goat and conjugated to Alexa 350 , 488 , or 594	15799
@NP	Secondary antibodies raised in goat and conjugated to Alexa 350 , 488	15799
@NP	Secondary antibodies	15799
@NP	goat	15830
@NP	Alexa 350 , 488	15853
@NP	594	15872
@NP	1 h at room temperature	15893
@NP	1 h	15893
@NP	room temperature	15900
@NP	sections	15922
@NP	Vectashield -LRB- Vector Laboratories -RRB-	15957
@NP	Vectashield	15957
@NP	Vector Laboratories	15970
@NP	Image analysis and quantification .	15992
@NP	Image	15992
@NP	analysis and quantification	15998
@NP	Z-stacked 200x or 100x , montaged digital images	16027
@NP	Z-stacked 200x	16027
@NP	100x , montaged digital images	16045
@NP	an Axioplan 2 microscope -LRB- Zeiss , Jena , Germany -RRB-	16094
@NP	an Axioplan 2 microscope	16094
@NP	Zeiss	16120
@NP	Jena	16127
@NP	Germany	16133
@NP	a digital camera -LRB- QImaging , Burnaby , British Columbia , Canada -RRB-	16143
@NP	a digital camera	16143
@NP	QImaging , Burnaby , British Columbia , Canada	16161
@NP	QImaging	16161
@NP	Burnaby	16171
@NP	British Columbia	16180
@NP	Canada	16198
@NP	Northern Eclipse software	16211
@NP	Empix Imaging	16238
@NP	Mississauga	16253
@NP	Ontario , Canada	16266
@NP	Northern Eclipse	16308
@NP	Photoshop 7.0 -LRB- Adobe Systems , San Jose , CA -RRB-	16326
@NP	Photoshop 7.0	16326
@NP	Adobe Systems	16341
@NP	San Jose	16356
@NP	CA	16366
@NP	SigmaScan Pro -LRB- SPSS , Chicago , IL -RRB-	16375
@NP	SigmaScan	16375
@NP	Pro -LRB- SPSS , Chicago , IL -RRB-	16385
@NP	Pro	16385
@NP	SPSS	16390
@NP	Chicago	16396
@NP	IL	16405
@NP	software	16409
@NP	Lesion area and cavity size	16419
@NP	Lesion area	16419
@NP	cavity size	16435
@NP	each animal	16467
@NP	the lesion area	16492
@NP	GFAP	16519
@NP	three defined levels , 0.65 , 0.9 , and 1.15 mm ventral in the spinal cord	16527
@NP	three	16527
@NP	levels , 0.65 , 0.9 , and 1.15 mm ventral in the spinal cord	16541
@NP	levels	16541
@NP	0.65	16549
@NP	0.9	16555
@NP	1.15 mm ventral in the spinal cord	16564
@NP	1.15 mm	16564
@NP	the spinal cord	16583
@NP	the total pixels in this area	16616
@NP	the total pixels	16616
@NP	this area	16636
@NP	GFAP immunodensitometry	16647
@NP	sections at 0.9 mm ventral for all animals in each treatment group	16688
@NP	sections	16688
@NP	0.9 mm ventral for all animals in each treatment group	16700
@NP	0.9 mm	16700
@NP	all animals in each treatment group	16718
@NP	all animals	16718
@NP	each treatment group	16733
@NP	a defined area size	16777
@NP	the lesion site	16804
@NP	the analogous area on the contralateral uninjured side of the spinal cord	16834
@NP	the analogous area	16834
@NP	the contralateral uninjured side of the spinal cord	16856
@NP	the contralateral uninjured side	16856
@NP	the spinal cord	16892
@NP	Autofluorescent items	16909
@NP	triplefluorescing items in black	16964
@NP	triplefluorescing items	16964
@NP	black	16991
@NP	All axon quantitation	16998
@NP	the three depths	17037
@NP	the spinal cord	17057
@NP	Quantitation	17085
@NP	the lesion site was performed by outlining the GFAP-reactive border	17105
@NP	the lesion site	17105
@NP	the GFAP-reactive border	17148
@NP	binning fluorescence	17174
@NP	axon staining	17200
@NP	four bins	17219
@NP	staining between animals	17243
@NP	staining	17243
@NP	animals	17260
@NP	the number of pixels in the top three bins	17274
@NP	the number	17274
@NP	pixels in the top three bins	17288
@NP	pixels	17288
@NP	the top three bins	17298
@NP	areas on either side of the lesion site	17335
@NP	areas	17335
@NP	either side of the lesion site	17344
@NP	either side	17344
@NP	the lesion site	17359
@NP	selection areas	17384
@NP	750,000 pixels	17410
@NP	0.5 and 1 mm rostral/caudal to the rostra	17428
@NP	0.5 and 1 mm rostral/caudal	17428
@NP	the rostra	17459
@NP	caudal lesion boundary	17471
@NP	lesion measured	17534
@NP	lesion	17534
@NP	pixels in the three top bins	17575
@NP	pixels	17575
@NP	the three top bins	17585
@NP	A similar strategy	17605
@NP	GFP + items at locations within the lesion site , or 0.5	17645
@NP	GFP + items	17645
@NP	locations within the lesion site , or 0.5	17659
@NP	locations within the lesion site	17659
@NP	locations	17659
@NP	the lesion site	17676
@NP	0.5	17696
@NP	the lesion site	17729
@NP	Items fluorescing in all three channels	17746
@NP	Items	17746
@NP	all three channels	17767
@NP	the number of GFP + pixels	17810
@NP	the number	17810
@NP	GFP + pixels	17824
@NP	GFP	17824
@NP	pixels	17829
@NP	selection areas	17856
@NP	750,000 pixels	17882
@NP	Analysis of angiogenesis and directionality	17898
@NP	Analysis	17898
@NP	angiogenesis and directionality	17910
@NP	programs designed on Matlab -LRB- MathWorks , Natick , MA -RRB-	17963
@NP	programs	17963
@NP	Matlab -LRB- MathWorks , Natick , MA -RRB-	17984
@NP	Matlab	17984
@NP	MathWorks	17992
@NP	Natick	18003
@NP	MA	18011
@NP	100x montaged images stained with anti-RECA	18025
@NP	100x montaged images	18025
@NP	anti-RECA	18059
@NP	two levels	18102
@NP	blood vessels above a threshold size	18114
@NP	blood vessels	18114
@NP	a threshold size	18134
@NP	a best-fit line	18192
@NP	Intersection points from lines	18221
@NP	Intersection points	18221
@NP	lines	18246
@NP	the same x -- y plane as the original image	18274
@NP	the same x	18274
@NP	y plane as the original image	18285
@NP	y plane	18285
@NP	the original image	18296
@NP	the number	18320
@NP	intersection points in the lesion site	18334
@NP	intersection points	18334
@NP	the lesion site	18357
@NP	an outline of the GFAP scar	18388
@NP	an outline	18388
@NP	the GFAP scar	18402
@NP	The scar area	18431
@NP	the image 100 times	18494
@NP	the image	18494
@NP	100 times	18504
@NP	a baseline value of directionality	18527
@NP	a baseline value	18527
@NP	directionality	18547
@NP	The ratio of directionality in the lesion and at the random points	18563
@NP	The ratio	18563
@NP	directionality in the lesion and at the random points	18576
@NP	directionality	18576
@NP	the lesion	18594
@NP	the random points	18612
@NP	t tests	18643
@NP	appropriate , orANOVAsfollowed by post hoc analysis using Tukey 's tests	18666
@NP	appropriate , orANOVAsfollowed by post hoc analysis	18666
@NP	post hoc	18699
@NP	post	18699
@NP	Tukey 's tests	18723
@NP	Tukey 's	18723
@NP	groups	18765
@NP	Graphical data	18773
@NP	error bars	18807
@NP	SEM	18831
@NP	Results Figure 1 .	18837
@NP	Results	18837
@NP	Figure 1	18845
@NP	LP and OB OECs	18855
@NP	similar antigenic and morphological properties	18878
@NP	14 DIV	18941
@NP	GFP + LP -LRB- A -RRB- and OB -LRB- B -RRB- OECs	18949
@NP	GFP	18949
@NP	LP -LRB- A -RRB-	18954
@NP	LP	18954
@NP	A	18958
@NP	OB -LRB- B -RRB- OECs	18965
@NP	OB	18965
@NP	B	18969
@NP	OECs	18972
@NP	p75 and S100betta -LRB- C , D -RRB-	18985
@NP	p75 and S100betta	18985
@NP	primarily a	19019
@NP	arrow	19042
@NP	morphology	19049
@NP	some fusiform cells -LRB- arrowhead -RRB-	19066
@NP	some fusiform cells	19066
@NP	arrowhead	19087
@NP	Scale bars , 100µm .	19107
@NP	Scale bars	19107
@NP	100µm	19119
@NP	Figure 2 .	19127
@NP	Figure	19127
@NP	2	19134
@NP	LP OECs and OB OECs	19137
@NP	LP OECs	19137
@NP	OB OECs	19149
@NP	their ability to migrate in vivo and in vitro	19167
@NP	vivo	19195
@NP	28 d after lesion	19217
@NP	28 d	19217
@NP	lesion	19228
@NP	R/C transplanted GFP + LP OECs -LRB- A -RRB-	19236
@NP	R/C	19236
@NP	GFP + LP OECs	19253
@NP	GFP	19253
@NP	LP OECs	19258
@NP	A	19267
@NP	their injection points -LRB- asterisk -RRB-	19283
@NP	their injection points	19283
@NP	asterisk	19307
@NP	the lesion site	19327
@NP	arrowhead	19344
@NP	GFAP immunoreaction -LRB- red pseudocolor -RRB-	19367
@NP	GFAP immunoreaction	19367
@NP	red pseudocolor	19388
@NP	R/C transplanted GFP + OB OECs -LRB- B -RRB-	19414
@NP	R/C	19414
@NP	GFP + OB OECs	19431
@NP	B	19445
@NP	injection points and lesion site	19468
@NP	injection points	19468
@NP	lesion site	19489
@NP	n = 4 of 4 animals with surviving GFP + cells	19502
@NP	n	19502
@NP	= 4	19503
@NP	4 animals with surviving GFP + cells	19509
@NP	4 animals	19509
@NP	GFP + cells	19534
@NP	GFP	19534
@NP	cells	19539
@NP	The larger area occupied by OB OECs -LRB- B -RRB-	19547
@NP	The larger area	19547
@NP	OB OECs -LRB- B -RRB-	19575
@NP	OB OECs	19575
@NP	B	19584
@NP	R/C LP OECs	19607
@NP	7 d -LRB- C -RRB-	19622
@NP	7 d	19622
@NP	C	19627
@NP	D	19631
@NP	Quantitative assessment of GFP	19634
@NP	Quantitative assessment	19634
@NP	GFP	19661
@NP	LP and OB OECs -LRB- in pixels -RRB-	19666
@NP	LP and OB OECs	19666
@NP	pixels	19685
@NP	1 and 0.5 mm rostral/caudal	19696
@NP	the lesion site	19735
@NP	significantly more GFP	19759
@NP	cells at 0.5 and 1mmcaudal in OB-treated rats	19783
@NP	cells	19783
@NP	0.5 and 1mmcaudal	19792
@NP	OB-treated rats	19813
@NP	LP OEC-treated rats -LRB- p ≤ 0.05 -RRB-	19837
@NP	LP OEC-treated rats	19837
@NP	p ≤ 0.05	19859
@NP	p	19859
@NP	≤ 0.05	19860
@NP	E , In vitro ,	19868
@NP	E	19868
@NP	a Boyden chamber migration assay	19887
@NP	OB OECs	19921
@NP	60 %	19937
@NP	LP OECs	19951
@NP	20 h on PLL	19965
@NP	20 h	19965
@NP	PLL	19973
@NP	the migratory difference	19982
@NP	laminin	20025
@NP	OB OECs	20038
@NP	85 %	20056
@NP	LP OECs -LRB- n = 3 ; p ≤ 0.02 , all groups -RRB-	20070
@NP	LP OECs	20070
@NP	n = 3 ; p ≤ 0.02 , all groups	20079
@NP	n = 3 ; p ≤ 0.02 , all	20079
@NP	n = 3	20079
@NP	n	20079
@NP	3	20081
@NP	p ≤ 0.02 , all	20084
@NP	p	20084
@NP	≤ 0.02	20085
@NP	groups	20096
@NP	Data	20105
@NP	mean ± SEM	20127
@NP	Scale bars , 250µm .	20138
@NP	Scale bars	20138
@NP	250µm	20150
@NP	Figure 3 .	20158
@NP	Figure	20158
@NP	3	20165
@NP	Lesion site area and cavity formation	20168
@NP	Lesion site area	20168
@NP	cavity formation	20189
@NP	LP	20223
@NP	OB-treated rats	20234
@NP	Astrogliosis	20251
@NP	direct transplantation	20280
@NP	Examples of the lesion site	20304
@NP	Examples	20304
@NP	the lesion site	20316
@NP	area	20332
@NP	anti-GFAP -LRB- red pseudocolor -RRB-	20352
@NP	anti-GFAP	20352
@NP	red pseudocolor	20363
@NP	cavities	20384
@NP	transplantation of GFP + OB OECs directly -LRB- A -RRB-	20404
@NP	transplantation	20404
@NP	GFP + OB OECs directly -LRB- A -RRB-	20423
@NP	GFP + OB OECs directly	20423
@NP	GFP + OB OECs	20423
@NP	A	20446
@NP	-LRB- B -RRB- or GFP + LP OECs	20468
@NP	-LRB- B -RRB-	20468
@NP	GFP + LP OECs	20475
@NP	C	20498
@NP	D	20521
@NP	Exemplar	20528
@NP	quantitation	20540
@NP	lesion site area -LRB- white line -RRB- and cavity	20563
@NP	lesion site area	20563
@NP	white line	20581
@NP	cavity	20597
@NP	yellow line	20615
@NP	E , Area of the lesion site	20629
@NP	E	20629
@NP	Area of the lesion site	20632
@NP	Area	20632
@NP	the lesion site	20640
@NP	direct OB-treated rats	20686
@NP	all other groups -LRB- n = 4 ; p ≤ 0.05 -RRB-	20723
@NP	all other groups	20723
@NP	n = 4 ; p ≤ 0.05	20741
@NP	n	20741
@NP	= 4 ; p ≤ 0.05	20742
@NP	= 4	20742
@NP	p ≤ 0.05	20746
@NP	p	20746
@NP	≤ 0.05	20747
@NP	F , The area of cavity formed in direct OB	20755
@NP	F	20755
@NP	The area of cavity formed in direct OB	20758
@NP	The area	20758
@NP	cavity formed in direct OB	20770
@NP	cavity	20770
@NP	direct OB	20787
@NP	LP	20827
@NP	direct and LP R/C rats -LRB- n = 4 ; p ≤ 0.05 and p ≤ 0.05 -RRB-	20830
@NP	direct and LP R/C rats	20830
@NP	n = 4 ; p ≤ 0.05 and p ≤ 0.05	20854
@NP	n = 4 ; p ≤ 0.05	20854
@NP	n = 4	20854
@NP	n	20854
@NP	4	20858
@NP	p ≤ 0.05	20861
@NP	p	20861
@NP	≤ 0.05	20863
@NP	p ≤ 0.05	20874
@NP	p	20874
@NP	≤ 0.05	20876
@NP	The area of cavity	20885
@NP	The area	20885
@NP	cavity	20897
@NP	rostrocaudal transplantation	20920
@NP	R/C LP OEC transplantation	20955
@NP	cavity formation compared with all groups -LRB- n = 4 ; p ≤ 0.05 -RRB-	21005
@NP	cavity formation	21005
@NP	all groups -LRB- n = 4 ; p ≤ 0.05 -RRB-	21036
@NP	all groups	21036
@NP	n = 4 ; p ≤ 0.05	21048
@NP	n	21048
@NP	= 4 ; p ≤ 0.05	21049
@NP	= 4	21049
@NP	p ≤ 0.05	21053
@NP	p	21053
@NP	≤ 0.05	21054
@NP	G , R/C LP OEC rats	21063
@NP	the smallest percentage of the lesion site with cavity	21092
@NP	the smallest percentage	21092
@NP	the lesion site with cavity	21119
@NP	the lesion site	21119
@NP	cavity	21140
@NP	n	21148
@NP	= 4 ; p ≤ 0.05	21150
@NP	= 4	21150
@NP	p ≤ 0.05	21155
@NP	p	21155
@NP	≤ 0.05	21158
@NP	Astrogliosis	21167
@NP	GFAP intensity	21195
@NP	a defined area around the lesion site	21213
@NP	a defined area	21213
@NP	the lesion site	21235
@NP	GFAP	21265
@NP	the contralateral side	21273
@NP	significantly decreased reactivity	21302
@NP	the lesion site in rostrocaudally -LRB- B , D -RRB-	21340
@NP	the lesion site	21340
@NP	B , D	21375
@NP	B	21375
@NP	D	21378
@NP	directly -LRB- A , C -RRB-	21388
@NP	directly	21388
@NP	A , C	21398
@NP	A	21398
@NP	C	21401
@NP	transplanted rats compared with control rats	21404
@NP	transplanted rats	21404
@NP	control rats	21436
@NP	rostrocaudal LP OEC transplantation	21463
@NP	an additional significant reduction in GFAP intensity	21510
@NP	an additional significant reduction	21510
@NP	GFAP intensity	21549
@NP	rostrocaudal OB OEC transplantation	21578
@NP	n = 4 for all groups except LP	21615
@NP	n	21615
@NP	4	21617
@NP	all groups except LP	21623
@NP	all groups	21623
@NP	LP	21641
@NP	n = 5	21652
@NP	n	21652
@NP	5	21654
@NP	p ≤ 0.001 , ** p ≤ 0.05 , *** p	21658
@NP	p	21658
@NP	≤ 0.001 , ** p ≤ 0.05 , *** p	21659
@NP	≤ 0.001 , ** p ≤ 0.05 ,	21659
@NP	≤ 0.001	21659
@NP	p	21669
@NP	≤ 0.05	21670
@NP	*** p	21677
@NP	≤ 0.01	21681
@NP	Data	21689
@NP	mean ± SEM	21711
@NP	Scale bars , 250µm .	21722
@NP	Scale bars	21722
@NP	250µm	21734
@NP	Figure 4 .	21742
@NP	Figure	21742
@NP	4	21749
@NP	OEC interactions with endogenous glia	21752
@NP	OEC interactions	21752
@NP	endogenous glia	21774
@NP	LP and OB OECs	21791
@NP	Schwann cell infiltration	21814
@NP	Rat-specific p75 positive -LRB- red -RRB-	21841
@NP	Rat-specific p75	21841
@NP	endogenous Schwann cells	21873
@NP	the lesion site in LP-treated -LRB- A -RRB- and OB-treated -LRB- C -RRB- rats	21909
@NP	the lesion site	21909
@NP	LP-treated -LRB- A -RRB- and OB-treated -LRB- C -RRB- rats	21928
@NP	A	21940
@NP	C	21960
@NP	both LP OECs -LRB- B , arrow -RRB- and OB OECs -LRB- D , arrow -RRB-	21994
@NP	both LP OECs -LRB- B , arrow -RRB- and OB OECs	21994
@NP	LP OECs -LRB- B , arrow -RRB-	21999
@NP	LP OECs	21999
@NP	B , arrow	22008
@NP	B	22008
@NP	arrow	22011
@NP	OB OECs	22022
@NP	astrocytes -LRB- GFAP ; blue , arrowhead -RRB-	22058
@NP	astrocytes	22058
@NP	GFAP ; blue , arrowhead	22070
@NP	GFAP	22070
@NP	blue , arrowhead	22076
@NP	blue	22076
@NP	arrowhead	22082
@NP	Scale bars , 250µm .	22094
@NP	Scale bars	22094
@NP	250µm	22106
@NP	Figure 5 .	22114
@NP	Figure	22114
@NP	5	22121
@NP	Neurofilament-positive axon sprouting into the lesion site	22124
@NP	Neurofilament-positive axon	22124
@NP	the lesion site	22167
@NP	rostrocaudal LP OEC transplantation	22205
@NP	OB R/C transplantation -LRB- C -RRB-	22242
@NP	OB R/C transplantation	22242
@NP	C	22266
@NP	fewer NF-positive axons	22280
@NP	the lesion site -LRB- arrowhead -RRB-	22319
@NP	the lesion site	22319
@NP	arrowhead	22336
@NP	OB direct -LRB- D -RRB-	22361
@NP	OB direct	22361
@NP	D	22372
@NP	LP R/C -LRB- A -RRB-	22376
@NP	LP R/C	22376
@NP	A	22384
@NP	direct -LRB- B -RRB- transplantation	22390
@NP	B	22398
@NP	E	22418
@NP	Fluorescence densitometry	22421
@NP	NF-positive pixels	22451
@NP	the lesion site , as determined by outlining the GFAP-reactive border	22477
@NP	the lesion site	22477
@NP	the GFAP-reactive border	22521
@NP	significantly greater NF-positive reactivity	22555
@NP	the lesion site	22607
@NP	all treated groups	22626
@NP	control groups -LRB- p ≤ 0.01 , all groups -RRB-	22659
@NP	control groups	22659
@NP	p ≤	22676
@NP	0.01 , all groups	22678
@NP	0.01	22678
@NP	all groups	22684
@NP	Reactivity	22697
@NP	LP R/C transplanted rats	22742
@NP	LP direct	22781
@NP	OB R/C and OB direct rats -LRB- n = 4 , 5 , 4 , 4 ; p ≤ 0.001 all groups -RRB-	22795
@NP	OB R/C and OB	22795
@NP	direct rats -LRB- n = 4 , 5 , 4 , 4 ; p ≤ 0.001 all groups -RRB-	22809
@NP	direct rats	22809
@NP	n = 4 , 5 , 4 , 4 ; p ≤ 0.001 all groups	22822
@NP	n = 4	22822
@NP	n	22822
@NP	4	22824
@NP	5 , 4	22827
@NP	5	22827
@NP	4	22830
@NP	4 ; p ≤ 0.001 all groups	22833
@NP	4	22833
@NP	p ≤ 0.001 all groups	22836
@NP	p	22836
@NP	≤ 0.001 all groups	22837
@NP	OB OEC transplanted rats	22874
@NP	OB OEC	22874
@NP	rats	22894
@NP	there	22900
@NP	significantly greater NF-positive pixels	22910
@NP	the lesion site in direct versus R/C rats -LRB- n04 ; p ≤ 0.05 -RRB-	22954
@NP	the lesion site	22954
@NP	direct versus R/C rats -LRB- n04 ; p ≤ 0.05 -RRB-	22973
@NP	direct	22973
@NP	R/C rats -LRB- n04 ; p ≤ 0.05 -RRB-	22987
@NP	R/C rats	22987
@NP	n04 ; p ≤ 0.05	22997
@NP	n04	22997
@NP	p ≤ 0.05	23002
@NP	p	23002
@NP	≤ 0.05	23003
@NP	Data	23011
@NP	mean ± SEM	23033
@NP	Scale bars , 100µm .	23044
@NP	Scale bars	23044
@NP	100µm	23056
@NP	Figure 6 .	23064
@NP	Figure	23064
@NP	6	23071
@NP	LP and OB OECs	23074
@NP	directional angiogenesis	23097
@NP	Angiogenesis , as recognized by anti-RECA immunoreaction -LRB- red -RRB- ,	23123
@NP	Angiogenesis	23123
@NP	anti-RECA immunoreaction -LRB- red -RRB-	23154
@NP	anti-RECA immunoreaction	23154
@NP	red	23180
@NP	the lesion site -LRB- arrowhead -RRB-	23200
@NP	the lesion site	23200
@NP	arrowhead	23217
@NP	OB direct -LRB- B -RRB- and R/C -LRB- C -RRB- and LP direct -LRB- D -RRB-	23231
@NP	OB direct -LRB- B -RRB-	23231
@NP	OB direct	23231
@NP	B	23242
@NP	R/C -LRB- C -RRB-	23249
@NP	R/C	23249
@NP	C	23254
@NP	LP direct -LRB- D -RRB-	23261
@NP	LP direct	23261
@NP	D	23272
@NP	R/C -LRB- E -RRB- rats	23279
@NP	R/C	23279
@NP	E	23284
@NP	rats	23287
@NP	F , Directionality	23293
@NP	F	23293
@NP	Directionality	23296
@NP	best-fit lines	23340
@NP	RECA-positive structures	23358
@NP	normal distributions	23397
@NP	each intersection point	23421
@NP	a contour map of intersection points	23458
@NP	a contour map	23458
@NP	intersection points	23475
@NP	Contour	23496
@NP	control -LRB- G -RRB-	23513
@NP	control	23513
@NP	G	23522
@NP	OB direct -LRB- H -RRB-	23526
@NP	OB direct	23526
@NP	H	23537
@NP	OB R/C -LRB- I -RRB-	23541
@NP	OB R/C	23541
@NP	I	23549
@NP	LP direct -LRB- J -RRB-	23554
@NP	LP direct	23554
@NP	J	23565
@NP	LP R/C	23574
@NP	K	23582
@NP	the number of intersections in a given area	23591
@NP	the number	23591
@NP	intersections in a given area	23605
@NP	intersections	23605
@NP	a given area	23622
@NP	the color scale bar	23652
@NP	The height	23673
@NP	the contour map in G	23687
@NP	the contour map	23687
@NP	G	23706
@NP	K falling within the lesion site -LRB- white outlines in G -- K -RRB-	23708
@NP	K falling	23708
@NP	the lesion site	23725
@NP	white	23742
@NP	G -- K	23760
@NP	G	23760
@NP	K	23762
@NP	anti-GFAP -LRB- green pseudocolor -RRB-	23782
@NP	anti-GFAP	23782
@NP	green pseudocolor	23793
@NP	the height	23831
@NP	the same area	23857
@NP	100 times	23887
@NP	the image to produce a directionality quotient	23908
@NP	a directionality quotient	23929
@NP	Directionality quotients and total number of blood vessels	23956
@NP	Directionality quotients	23956
@NP	total number of blood vessels	23985
@NP	total number	23985
@NP	blood vessels	24001
@NP	tissue area	24031
@NP	Table 1	24061
@NP	Scale bars , 250µm .	24070
@NP	Scale bars	24070
@NP	250µm	24082
@NP	Figure 7 .	24090
@NP	Figure	24090
@NP	7	24097
@NP	Autotomy	24100
@NP	OB OEC transplantation	24123
@NP	LP OEC transplantation	24162
@NP	Schematic of scoring system for autotomy	24189
@NP	Schematic	24189
@NP	scoring system for autotomy	24202
@NP	scoring system	24202
@NP	autotomy	24221
@NP	scores	24251
@NP	1 , 2 , and 3 , respectively	24279
@NP	1 , 2 , and 3	24279
@NP	B , Direct LP	24306
@NP	OEC-treated rats	24319
@NP	significantly greater autotomy	24341
@NP	direct OB OEC-transplanted rats and control rats	24377
@NP	n	24427
@NP	= 5 , 4 , 5	24428
@NP	= 5	24428
@NP	4	24432
@NP	5	24435
@NP	p ≤ 0.01 , *** p	24439
@NP	p	24439
@NP	≤ 0.01 , *** p	24440
@NP	≤ 0.01	24440
@NP	*** p	24447
@NP	0.05	24452
@NP	R/C LP OEC rats	24459
@NP	significantly increased autotomy	24483
@NP	R/C OB OEC-transplanted rats -LRB- n = 4 , 4 ; ** p ≤ 0.05 -RRB-	24530
@NP	R/C OB OEC-transplanted rats	24530
@NP	n	24560
@NP	= 4 , 4	24561
@NP	= 4	24561
@NP	p	24570
@NP	≤ 0.05	24571
@NP	they	24583
@NP	control rats	24621
@NP	R/C OB rats	24635
@NP	significantly decreased autotomy	24654
@NP	control rats -LRB- p ≤ 0.05 -RRB-	24701
@NP	control rats	24701
@NP	p ≤ 0.05	24716
@NP	p	24716
@NP	≤ 0.05	24717
@NP	Data	24725
@NP	mean ± SEM	24747
@NP	Figure 8 .	24759
@NP	Figure	24759
@NP	8	24766
@NP	TH-positive and subP-positive axons	24769
@NP	LP and OB OEC transplantation	24838
@NP	subP axons	24869
@NP	response	24895
@NP	LP OEC -LRB- A -RRB-	24907
@NP	LP OEC	24907
@NP	A	24915
@NP	than to OB OEC -LRB- B -RRB- transplantation	24918
@NP	OB OEC -LRB- B -RRB-	24926
@NP	OB OEC	24926
@NP	B	24934
@NP	C , Quantification of subP-positive pixels by fluorescence densitometry	24954
@NP	C	24954
@NP	Quantification of subP-positive pixels by fluorescence densitometry	24957
@NP	Quantification	24957
@NP	subP-positive pixels by fluorescence densitometry	24975
@NP	subP-positive pixels	24975
@NP	fluorescence densitometry	24999
@NP	increased subP in OB OEC animals 1	25045
@NP	increased subP in OB OEC animals	25045
@NP	increased subP	25045
@NP	OB OEC animals	25063
@NP	1	25078
@NP	0.5 mmrostral and caudal	25084
@NP	0.5 mmrostral	25084
@NP	caudal	25101
@NP	the lesion site	25111
@NP	the lesion site compared with LP-treated rats	25138
@NP	the lesion site	25138
@NP	LP-treated rats	25168
@NP	n = 9 , 8 ; p ≤ 0.05 , all groups	25185
@NP	n = 9	25185
@NP	n	25185
@NP	9	25187
@NP	8 ; p ≤ 0.05	25190
@NP	8	25190
@NP	p ≤ 0.05	25193
@NP	p	25193
@NP	≤ 0.05	25194
@NP	all groups	25201
@NP	all	25201
@NP	groups	25205
@NP	CGRP-positive axons	25214
@NP	response to LP -LRB- D -RRB- and OB -LRB- E -RRB- OEC transplantation	25244
@NP	response to LP -LRB- D -RRB-	25244
@NP	response	25244
@NP	LP -LRB- D -RRB-	25256
@NP	LP	25256
@NP	D	25260
@NP	OB -LRB- E -RRB- OEC transplantation	25267
@NP	OB	25267
@NP	E	25271
@NP	OEC transplantation	25274
@NP	control groups -LRB- p ≤ 0.001 -RRB-	25308
@NP	control groups	25308
@NP	p ≤ 0.001	25325
@NP	p	25325
@NP	≤ 0.001	25326
@NP	0.5 mm rostral	25364
@NP	the lesion in LP than OB rats -LRB- n = 9 , 8 ; p ≤ 0.05 -RRB- -LRB- F -RRB-	25382
@NP	the lesion	25382
@NP	LP than OB rats -LRB- n = 9 , 8 ; p ≤ 0.05 -RRB- -LRB- F -RRB-	25396
@NP	LP	25396
@NP	OB rats -LRB- n = 9 , 8 ; p ≤ 0.05 -RRB- -LRB- F -RRB-	25404
@NP	OB rats -LRB- n = 9 , 8 ; p ≤ 0.05 -RRB-	25404
@NP	OB rats	25404
@NP	n = 9 , 8 ; p ≤ 0.05	25413
@NP	n	25413
@NP	= 9 , 8 ; p ≤ 0.05	25414
@NP	= 9 , 8	25414
@NP	= 9	25414
@NP	8	25418
@NP	p ≤ 0.05	25421
@NP	p	25421
@NP	≤ 0.05	25422
@NP	F	25430
@NP	The quantity and distribution	25435
@NP	5-HT-positive axons	25478
@NP	LP -LRB- G -RRB- and OB -LRB- H -RRB-	25501
@NP	LP	25501
@NP	G	25505
@NP	OB	25512
@NP	H	25516
@NP	OEC-treated rats	25519
@NP	robust growth rostral to and within the lesion site -LRB- I -RRB-	25553
@NP	robust growth rostral	25553
@NP	the lesion site	25589
@NP	I	25606
@NP	control animals	25624
@NP	p ≤ 0.05	25642
@NP	p	25642
@NP	≤ 0.05	25643
@NP	few axons	25656
@NP	the lesion -LRB- G , H , insets -RRB-	25686
@NP	the lesion	25686
@NP	G , H , insets	25698
@NP	G	25698
@NP	H	25701
@NP	insets	25704
@NP	TH axons	25713
@NP	more to LP OEC -LRB- J -RRB- than to OB OEC -LRB- K -RRB- transplantation	25730
@NP	LP OEC -LRB- J -RRB-	25738
@NP	LP OEC	25738
@NP	J	25746
@NP	OB OEC	25758
@NP	K	25766
@NP	L , TH growth , quantified by immunofluorescence densitometry ,	25787
@NP	L	25787
@NP	TH growth	25790
@NP	immunofluorescence densitometry	25815
@NP	LP OEC-treated rats 1 and 0.5 mmrostral to and within the lesion site	25878
@NP	LP OEC-treated rats 1	25878
@NP	LP OEC-treated rats	25878
@NP	1	25898
@NP	0.5 mmrostral to and within the lesion site	25904
@NP	0.5 mmrostral	25904
@NP	the lesion site	25931
@NP	the same sites	25972
@NP	OB OEC-treated rats and control rats -LRB- K , inset -RRB-	25990
@NP	OB OEC-treated rats	25990
@NP	control rats -LRB- K , inset -RRB-	26014
@NP	control rats	26014
@NP	K , inset	26028
@NP	K	26028
@NP	n = 9 , 8 , 8 ; p ≤ 0.001 and p ≤ 0.001	26039
@NP	n = 9	26039
@NP	n	26039
@NP	9	26041
@NP	8 , 8 ; p ≤ 0.001	26044
@NP	8 , 8	26044
@NP	8	26044
@NP	8	26047
@NP	p ≤ 0.001	26050
@NP	p	26050
@NP	≤ 0.001	26051
@NP	p ≤ 0.001	26062
@NP	p	26062
@NP	≤ 0.001	26063
@NP	All axons	26072
@NP	Data	26093
@NP	mean ± SEM	26115
@NP	Scale bars , 100µm .	26126
@NP	Scale bars	26126
@NP	100µm	26138
@NP	their comparative ability	26156
@NP	regeneration	26193
@NP	OECs	26207
@NP	the LP or OB of postnatal day 5 mice homozygous for eGFP	26231
@NP	the LP or OB	26231
@NP	postnatal day 5 mice homozygous for eGFP	26247
@NP	postnatal day	26247
@NP	5 mice	26261
@NP	eGFP	26283
@NP	the betta-actin promoter	26294
@NP	Ramon	26320
@NP	Cueto and Nieto-Sampedro , 1994 ; Au and Roskams , 2003	26327
@NP	Cueto and Nieto-Sampedro	26327
@NP	1994 ; Au and Roskams	26353
@NP	1994	26353
@NP	Au and Roskams	26359
@NP	2003	26375
@NP	LP -LRB- Fig. 1A , C -RRB- and OB -LRB- Fig. 1B , D -RRB- OECs grown for 14 DIV	26382
@NP	LP -LRB- Fig. 1A , C -RRB- and OB -LRB- Fig. 1B , D -RRB- OECs	26382
@NP	LP -LRB- Fig. 1A , C -RRB-	26382
@NP	LP	26382
@NP	Fig. 1A , C	26386
@NP	Fig. 1A	26386
@NP	C	26394
@NP	OB -LRB- Fig. 1B , D -RRB- OECs	26401
@NP	OB	26401
@NP	Fig. 1B , D	26405
@NP	Fig. 1B	26405
@NP	D	26413
@NP	OECs	26416
@NP	14 DIV	26431
@NP	similar morphologic and antigenic profiles	26451
@NP	S100betta , GFAP , and the p75 neurotrophin receptor	26498
@NP	S100betta	26498
@NP	GFAP	26509
@NP	the p75 neurotrophin receptor	26519
@NP	LP and OB OECs	26550
@NP	and fusiform morphologies -LRB- Fig. 1A , B -RRB-	26590
@NP	fusiform morphologies -LRB- Fig. 1A , B -RRB-	26594
@NP	fusiform morphologies	26594
@NP	Fig. 1A , B	26617
@NP	Fig. 1A	26617
@NP	B	26625
@NP	OB OECs	26629
@NP	a broader range of p75 expression	26650
@NP	a broader range	26650
@NP	p75 expression	26669
@NP	LP OECs	26689
@NP	some OB OECs	26698
@NP	highly p75 positive	26716
@NP	the majority	26745
@NP	low p75 levels -LRB- Fig. 1B -RRB-	26771
@NP	low p75 levels	26771
@NP	Fig. 1B	26787
@NP	their antigenic similarity	26805
@NP	LP OECs	26833
@NP	a threefold higher expansion rate than OB OECs	26854
@NP	a threefold higher expansion rate	26854
@NP	OB OECs	26893
@NP	passage 1	26906
@NP	2 under the same culture conditions	26916
@NP	2	26916
@NP	the same culture conditions	26924
@NP	passage 2 eGFP + LP and OB OECs cultured for 14 DIV	26962
@NP	passage 2 eGFP	26962
@NP	LP and OB OECs cultured for 14 DIV	26978
@NP	LP and OB OECs	26978
@NP	14 DIV	27006
@NP	or at sites 1mmrostral and caudal	27052
@NP	or at sites	27052
@NP	a crush of the dorsolateral funiculus	27089
@NP	a crush	27089
@NP	the dorsolateral funiculus	27100
@NP	We	27128
@NP	differences	27147
@NP	LP and OB OECs	27167
@NP	their home environments	27213
@NP	the PNS and CNS compartments	27240
@NP	the olfactory system	27272
@NP	the CNS and preferential interactions	27333
@NP	the CNS	27333
@NP	preferential interactions	27345
@NP	endogenous glia	27376
@NP	We	27393
@NP	R/C-transplanted LP and OB OECs	27411
@NP	different patterns of migration within the CNS	27453
@NP	different patterns	27453
@NP	migration within the CNS	27475
@NP	migration	27475
@NP	the CNS	27492
@NP	their change	27513
@NP	distribution from 24 h	27529
@NP	distribution	27529
@NP	24 h	27547
@NP	28 d after lesion -LRB- Fig. 2 -RRB-	27555
@NP	28 d	27555
@NP	lesion -LRB- Fig. 2 -RRB-	27566
@NP	lesion	27566
@NP	Fig. 2	27574
@NP	24 h after injection	27586
@NP	24 h	27586
@NP	injection	27597
@NP	25 ± 7.7 % of all transplanted LP OECs and 30 ± 6.9 % of OB OECs	27608
@NP	25 ± 7.7 %	27608
@NP	25 ±	27608
@NP	all transplanted LP OECs and 30 ± 6.9 % of OB OECs	27621
@NP	all transplanted LP OECs	27621
@NP	30 ± 6.9 % of OB OECs	27650
@NP	30 ±	27650
@NP	OB OECs	27661
@NP	the lesion site	27691
@NP	both types of OECs	27712
@NP	both types	27712
@NP	OECs	27726
@NP	a stream from the rostral injection point	27758
@NP	a stream	27758
@NP	the rostral injection point	27772
@NP	lesion center	27803
@NP	we	27826
@NP	cells	27846
@NP	the caudal injection point	27860
@NP	42 ± 10.6 % of total LP-OECs and 28 ± 6.2 % OB OECs transplanted	27903
@NP	10.6 % of total LP-OECs and 28 ± 6.2 % OB OECs transplanted	27906
@NP	10.6 % of total LP-OECs	27906
@NP	10.6 %	27906
@NP	total LP-OECs	27915
@NP	28 ± 6.2 % OB OECs transplanted	27933
@NP	28 ± 6.2 % OB OECs	27933
@NP	6.2 %	27936
@NP	lesion site	27967
@NP	four of five LP and three of four OB-transplanted rats	27983
@NP	four of five LP	27983
@NP	four	27983
@NP	five LP	27991
@NP	three of four OB-transplanted rats	28003
@NP	three	28003
@NP	four OB-transplanted rats	28012
@NP	this	28040
@NP	fluid pressure	28059
@NP	a subset of OECs from their rostral but not their caudal injection point	28097
@NP	a subset of OECs from their rostral	28097
@NP	a subset	28097
@NP	OECs from their rostral	28109
@NP	OECs	28109
@NP	their rostral	28119
@NP	their caudal injection point	28141
@NP	Migration of GFP + OECs from the caudal injection point to the lesion site	28171
@NP	Migration	28171
@NP	GFP + OECs from the caudal injection point to the lesion site	28184
@NP	GFP + OECs	28184
@NP	the caudal injection point to the lesion site	28199
@NP	the caudal injection point	28199
@NP	the lesion site	28229
@NP	28 d in LP - and OB-transplanted rats	28260
@NP	28 d	28260
@NP	LP - and OB-transplanted rats	28268
@NP	GFP + OECs -LRB- three of four LP and four of four OB -RRB-	28312
@NP	GFP + OECs	28312
@NP	three of four LP and four of four OB	28323
@NP	three of four LP	28323
@NP	three	28323
@NP	four LP	28332
@NP	four of four OB	28344
@NP	four	28344
@NP	four OB	28352
@NP	Fig. 2A , B	28362
@NP	Fig. 2A	28362
@NP	B	28370
@NP	the frequency and distribution	28383
@NP	OECs between the injection and the lesion sites	28417
@NP	OECs	28417
@NP	the injection and the lesion sites	28430
@NP	the injection	28430
@NP	the lesion sites	28448
@NP	OEC types	28496
@NP	n = 3 , 4 ; p ≤ 0.05	28507
@NP	n	28507
@NP	= 3 , 4 ; p ≤ 0.05	28509
@NP	= 3 , 4	28509
@NP	= 3	28509
@NP	4	28514
@NP	p ≤ 0.05	28517
@NP	p	28517
@NP	≤ 0.05	28519
@NP	transplanted rats	28543
@NP	more GFP + OECs at 28 d	28565
@NP	more GFP	28565
@NP	more	28565
@NP	GFP	28570
@NP	OECs at 28 d	28575
@NP	OECs	28575
@NP	28 d	28583
@NP	directly transplanted rats -LRB- 0 of 5 LP OECs ; one of four OB OECs -RRB-	28593
@NP	directly transplanted rats	28593
@NP	0 of 5 LP OECs ; one of four OB OECs	28621
@NP	0	28621
@NP	5 LP OECs ; one of four OB OECs	28626
@NP	5 LP OECs	28626
@NP	one of four OB OECs	28637
@NP	one	28637
@NP	four OB OECs	28644
@NP	GFP + OEC distribution	28674
@NP	GFP	28674
@NP	OEC distribution	28679
@NP	≈ 45 % of surviving GFP + OB OECs in rostrocaudally transplanted rats	28696
@NP	≈ 45 %	28696
@NP	GFP + OB OECs in rostrocaudally transplanted rats	28714
@NP	GFP + OB OECs	28714
@NP	rostrocaudally transplanted rats	28730
@NP	the caudal injection point and lesion site -LRB- n = 4 -RRB- -LRB- Fig. 2D -RRB-	28788
@NP	the caudal injection point and lesion site -LRB- n = 4 -RRB-	28788
@NP	the caudal injection point and lesion site	28788
@NP	n	28832
@NP	4	28836
@NP	Fig. 2D	28840
@NP	similar to the distribution of LP OECs 7 d after injury	28850
@NP	similar to the distribution of LP OECs	28850
@NP	the distribution of LP	28861
@NP	the distribution	28861
@NP	LP	28881
@NP	injury	28899
@NP	rostrocaudal transplantation -LRB- Fig. 3C -RRB-	28910
@NP	rostrocaudal transplantation	28910
@NP	Fig. 3C	28940
@NP	contrast	28953
@NP	28 d	28966
@NP	only ≈ 6 % of surviving LP OECs	28972
@NP	only ≈ 6 %	28972
@NP	surviving LP OECs	28984
@NP	the caudal injection point -LRB- Fig. 2A -RRB-	29016
@NP	the caudal injection point	29016
@NP	Fig. 2A	29044
@NP	51 % of surviving GFP + cells found within the lesion site	29059
@NP	51 %	29059
@NP	GFP + cells found within the lesion site	29076
@NP	GFP + cells	29076
@NP	the lesion site	29100
@NP	migratory differences in vivo	29144
@NP	migratory differences	29144
@NP	vivo	29169
@NP	intrinsic differences	29186
@NP	migratory ability of LP and OB OECs	29211
@NP	migratory ability	29211
@NP	LP and OB OECs	29232
@NP	a Boyden chamber assay	29248
@NP	Cells	29281
@NP	a	29299
@NP	poly-L-lysine	29327
@NP	normal OEC substrate	29342
@NP	laminin	29367
@NP	the lesion site	29384
@NP	Ramer	29402
@NP	et al. , 2004b	29408
@NP	et al.	29408
@NP	2004b	29416
@NP	the membrane	29465
@NP	the ratios of migratory versus nonmigratory cells	29483
@NP	the ratios	29483
@NP	migratory versus nonmigratory cells	29497
@NP	migratory	29497
@NP	nonmigratory cells	29514
@NP	20 h	29550
@NP	a significantly greater number of LP OECs	29556
@NP	a significantly greater number	29556
@NP	LP OECs	29590
@NP	thanOBOECs	29607
@NP	PLL -LRB- n = 3 ; p ≤ 0.02 -RRB-	29621
@NP	PLL	29621
@NP	n = 3 ; p ≤ 0.02	29626
@NP	n	29626
@NP	= 3 ; p ≤ 0.02	29628
@NP	= 3	29628
@NP	p ≤ 0.02	29633
@NP	p	29633
@NP	≤ 0.02	29635
@NP	this effect	29648
@NP	laminin -LRB- n = 3 ; p ≤ 0.02 -RRB-	29677
@NP	laminin	29677
@NP	n = 3 ; p ≤ 0.02	29686
@NP	n	29686
@NP	= 3 ; p ≤ 0.02	29688
@NP	= 3	29688
@NP	p ≤ 0.02	29693
@NP	p	29693
@NP	≤ 0.02	29695
@NP	85 % fewer OB OECs	29713
@NP	85 %	29713
@NP	Fig. 2E	29741
@NP	These data	29751
@NP	vivo	29779
@NP	LP OECs	29798
@NP	OB OECs	29832
@NP	Lesion site area and cavity formation	29841
@NP	LP versus OB OEC transplantation Differences	29896
@NP	LP	29896
@NP	OB OEC transplantation Differences	29906
@NP	migratory ability	29944
@NP	LP and OB OECs	29989
@NP	lesion and cavity formation	30025
@NP	the acute phase of SCI	30060
@NP	the acute phase	30060
@NP	SCI	30079
@NP	differential migration	30100
@NP	lesion size	30139
@NP	we	30152
@NP	the GFAPreactive border	30160
@NP	a marker of the perimeter of the lesion area	30187
@NP	a marker	30187
@NP	the perimeter of the lesion area	30199
@NP	the perimeter	30199
@NP	the lesion area	30216
@NP	lesion area	30245
@NP	cavity area	30258
@NP	the percentage of the lesion site occupied by cavity -LRB- Fig. 3A -RRB-	30275
@NP	the percentage	30275
@NP	the lesion site	30293
@NP	cavity -LRB- Fig. 3A -RRB-	30321
@NP	cavity	30321
@NP	Fig. 3A	30329
@NP	All groups	30339
@NP	an easily defined lesion area containing some evidence of a cavity	30360
@NP	an easily defined lesion area	30360
@NP	some evidence of a cavity	30401
@NP	some evidence	30401
@NP	a cavity	30418
@NP	rats that received directOBOEC transplants -LRB- Fig. 3A -RRB-	30437
@NP	rats	30437
@NP	directOBOEC transplants -LRB- Fig. 3A -RRB-	30456
@NP	directOBOEC transplants	30456
@NP	Fig. 3A	30481
@NP	a significantly increased lesion	30494
@NP	site area -LRB- by approximately twofold to threefold -RRB-	30527
@NP	site area	30527
@NP	rats that received the same cells rostrocaudally -LRB- Fig. 3B -RRB-	30591
@NP	rats	30591
@NP	the same cells	30610
@NP	Fig. 3B	30641
@NP	rats	30658
@NP	LP OECs transplanted either directly -LRB- Fig. 3C -RRB- or rostrocaudally	30677
@NP	LP OECs transplanted either directly -LRB- Fig. 3C -RRB-	30677
@NP	LP OECs transplanted either directly	30677
@NP	LP OECs	30677
@NP	Fig. 3C	30715
@NP	n = 4 all groups ; p ≤ 0.02	30743
@NP	n	30743
@NP	= 4 all groups ; p ≤ 0.02	30745
@NP	= 4 all groups	30745
@NP	= 4	30745
@NP	all groups	30749
@NP	p ≤ 0.02	30761
@NP	p	30761
@NP	≤ 0.02	30763
@NP	Fig. 3D	30772
@NP	Rats that received direct or rostrocaudally transplanted LP OECs	30782
@NP	Rats that received direct	30782
@NP	Rats	30782
@NP	rostrocaudally transplanted LP OECs	30811
@NP	smaller cavities	30862
@NP	rats	30884
@NP	direct OB OEC transplants	30894
@NP	n 5 , 4	30921
@NP	n 5	30921
@NP	4	30926
@NP	4 ; p ≤ 0.02 and 0.04 , respectively	30929
@NP	4	30929
@NP	p ≤ 0.02 and 0.04 , respectively	30932
@NP	p ≤	30932
@NP	0.02 and 0.04	30936
@NP	Fig. 3F	30966
@NP	The greatest significant decrease in cavity formation	30976
@NP	The greatest significant decrease	30976
@NP	cavity formation	31013
@NP	rats that received LP OECs transplanted rostrocaudally -LRB- Fig. 3F -RRB-	31037
@NP	rats	31037
@NP	LP OECs transplanted rostrocaudally	31056
@NP	LP OECs	31056
@NP	Fig. 3F	31093
@NP	a significantly lower percentage	31126
@NP	the lesion site	31162
@NP	cavity -LRB- Fig. 3G -RRB-	31190
@NP	cavity	31190
@NP	Fig. 3G	31198
@NP	a trend	31208
@NP	rostrocaudal OB OEC transplantation	31235
@NP	Fig. 3G	31272
@NP	The smaller lesion site area in rostrocaudally	31282
@NP	The smaller lesion site area	31282
@NP	transplanted LP and OB OEC rats and directly transplanted LP OEC rats	31329
@NP	transplanted LP and OB OEC rats	31329
@NP	transplanted LP	31329
@NP	OB OEC rats	31349
@NP	directly transplanted LP OEC rats	31365
@NP	four times	31403
@NP	that	31427
@NP	control animals	31440
@NP	cavities an average of 46 times larger -LRB- p ≤ 0.01 , all groups -RRB-	31478
@NP	cavities	31478
@NP	an average	31487
@NP	46 times larger -LRB- p ≤ 0.01 , all groups -RRB-	31501
@NP	46 times larger	31501
@NP	p ≤	31519
@NP	0.01 , all groups	31523
@NP	0.01	31523
@NP	all groups	31529
@NP	transplanted rats	31546
@NP	93 ± 3.3 %	31575
@NP	93 ±	31575
@NP	the lesion site	31588
@NP	Reactive astrogliosis	31605
@NP	rostrocaudal transplantation	31641
@NP	The physical barrier of the lesion site and cavity	31670
@NP	The physical barrier	31670
@NP	the lesion site and cavity	31694
@NP	major obstacles to axonal regeneration -LRB- Schwab , 2002 -RRB-	31725
@NP	major obstacles	31725
@NP	axonal regeneration -LRB- Schwab , 2002 -RRB-	31744
@NP	axonal regeneration	31744
@NP	Schwab	31765
@NP	2002	31773
@NP	the astro - cytic scar , produced by reactive astrocytes ,	31789
@NP	the astro	31789
@NP	cytic scar , produced by reactive astrocytes	31800
@NP	cytic scar	31800
@NP	reactive astrocytes	31824
@NP	growthinhibitory molecules	31854
@NP	an additional chemical obstacle	31891
@NP	growing axons -LRB- Moreau-Fauvarque et al. , 2003 ; Camand et al. , 2004 -RRB-	31926
@NP	growing axons	31926
@NP	Moreau-Fauvarque	31941
@NP	et al. , 2003 ; Camand et al. , 2004	31958
@NP	et al.	31958
@NP	2003 ; Camand et al.	31966
@NP	2003	31966
@NP	Camand et al.	31972
@NP	Camand	31972
@NP	et al.	31979
@NP	2004	31987
@NP	both the OEC type and method of introduction	32002
@NP	the OEC type	32007
@NP	method of introduction	32024
@NP	method	32024
@NP	introduction	32034
@NP	the lesion site and cavity area	32069
@NP	we	32102
@NP	inhibitory astrogliosis	32123
@NP	treatment groups	32182
@NP	All groups	32200
@NP	the distribution of GFAP-expressing astrocytes -LRB- Fig. 3A -- D -RRB-	32227
@NP	the distribution	32227
@NP	GFAP-expressing astrocytes -LRB- Fig. 3A -- D -RRB-	32247
@NP	GFAP-expressing astrocytes	32247
@NP	Fig. 3A -- D	32275
@NP	Fig. 3A	32275
@NP	D	32283
@NP	The intensity of GFAP immunoreactivity surrounding and including the lesion site	32287
@NP	The intensity	32287
@NP	GFAP immunoreactivity surrounding and including the lesion site	32304
@NP	GFAP immunoreactivity	32304
@NP	the lesion site	32352
@NP	an equally sized	32386
@NP	area of GFAP immunoreactivity contralateral	32411
@NP	area	32411
@NP	GFAP immunoreactivity contralateral	32419
@NP	the lesion site	32458
@NP	This	32475
@NP	between-animal differences in baseline reactivity and background staining	32495
@NP	between-animal differences	32495
@NP	baseline reactivity and background staining	32525
@NP	baseline reactivity	32525
@NP	background staining	32549
@NP	Direct transplantation of LP and OB OECs	32570
@NP	Direct transplantation	32570
@NP	LP and OB OECs	32596
@NP	a reactive astrogliosis	32620
@NP	extent	32655
@NP	injection of media -LRB- Fig. 3A , C , H -RRB-	32672
@NP	injection	32672
@NP	media -LRB- Fig. 3A , C , H -RRB-	32685
@NP	media	32685
@NP	Fig. 3A	32692
@NP	C	32700
@NP	H	32702
@NP	contrast	32709
@NP	rostrocaudal injection of media	32719
@NP	rostrocaudal injection	32719
@NP	media	32745
@NP	the most extensive astrogliosis	32762
@NP	all treatment groups	32797
@NP	a reaction	32819
@NP	transplantation of both OEC types rostral and caudal	32864
@NP	transplantation	32864
@NP	both OEC types rostral and caudal	32883
@NP	OEC types rostral	32888
@NP	caudal	32910
@NP	the lesion -LRB- n = 4 , 4 , 4 ; LP , p ≤ 0.001 ; OB , p ≤ 0.01 -RRB-	32920
@NP	the lesion	32920
@NP	n = 4 , 4 , 4 ; LP , p ≤ 0.001 ; OB , p ≤ 0.01	32932
@NP	n = 4 , 4 , 4 ; LP , p ≤ 0.001 ; OB , p	32932
@NP	n = 4	32932
@NP	n	32932
@NP	4	32936
@NP	4 , 4 ; LP , p ≤ 0.001 ; OB , p	32939
@NP	4 , 4	32939
@NP	4	32939
@NP	4	32942
@NP	LP , p ≤ 0.001	32945
@NP	LP	32945
@NP	p ≤ 0.001	32949
@NP	p	32949
@NP	≤ 0.001	32951
@NP	OB , p	32960
@NP	OB	32960
@NP	p	32964
@NP	≤ 0.01	32966
@NP	Rostrocaudal transplantation of both LP and OB OECs	32975
@NP	Rostrocaudal transplantation	32975
@NP	both LP and OB OECs	33007
@NP	LP	33012
@NP	OB OECs	33019
@NP	GFAP intensity	33056
@NP	direct transplantation	33085
@NP	rostrocaudal LP OEC transplantation	33114
@NP	GFAP reactivity	33160
@NP	the greatest extent -LRB- n 4 , 4 , 5 , 4 , 4 , 4 ; p ≤ 0.05 -RRB-	33179
@NP	the greatest extent	33179
@NP	n 4 , 4 , 5 , 4 , 4	33200
@NP	n 4	33200
@NP	4	33205
@NP	5	33208
@NP	4	33211
@NP	4	33214
@NP	4 ; p ≤ 0.05	33217
@NP	4	33217
@NP	p ≤ 0.05	33220
@NP	p	33220
@NP	≤ 0.05	33222
@NP	Fig. 3H	33231
@NP	The reduced astrocytic reaction	33241
@NP	rostrocaudal versus direct transplanted rats	33285
@NP	rostrocaudal	33285
@NP	direct transplanted rats	33305
@NP	this method of transplantation	33344
@NP	this method	33344
@NP	transplantation	33359
@NP	a more permissive environment	33386
@NP	axon extension -LRB- Lakatos et al. , 2003 -RRB-	33420
@NP	axon extension	33420
@NP	Lakatos	33436
@NP	et al. , 2003	33444
@NP	et al.	33444
@NP	2003	33452
@NP	no additional decrease	33468
@NP	CSPG expression between treated groups	33507
@NP	CSPG expression	33507
@NP	treated groups	33531
@NP	data not shown	33547
@NP	data	33547
@NP	that reported previously	33568
@NP	that	33568
@NP	Ramer	33594
@NP	et al. , 2004b	33600
@NP	et al.	33600
@NP	2004b	33608
@NP	LP and OB OECs	33616
@NP	endogenous Schwann cells	33649
@NP	the lesion site Interactions between OECs and glia other	33677
@NP	the lesion site Interactions	33677
@NP	OECs and glia other	33714
@NP	OECs	33714
@NP	glia other	33723
@NP	astrocytes	33739
@NP	regeneration outcomes	33782
@NP	Schwann cells -LRB- SCs -RRB-	33805
@NP	Schwann cells	33805
@NP	SCs	33820
@NP	regeneration	33851
@NP	regeneration and remyelination	33919
@NP	CNS lesions -LRB- Bunge , 2002 -RRB-	33956
@NP	CNS lesions	33956
@NP	Bunge	33969
@NP	2002	33976
@NP	We	33983
@NP	part of the mechanism whereby OECs may stimulate regeneration	34017
@NP	part	34017
@NP	the mechanism whereby OECs may stimulate regeneration	34025
@NP	the mechanism	34025
@NP	OECs	34047
@NP	regeneration	34066
@NP	the infiltration of endogenous SCs	34111
@NP	the infiltration	34111
@NP	endogenous SCs	34131
@NP	the spinal cord -LRB- Ramer et al. , 2004b -RRB-	34151
@NP	the spinal cord	34151
@NP	Ramer	34168
@NP	et al. , 2004b	34174
@NP	et al.	34174
@NP	2004b	34182
@NP	we	34199
@NP	OB OECs	34222
@NP	SC infiltration in this lesion paradigm	34243
@NP	SC infiltration	34243
@NP	this lesion paradigm	34262
@NP	Immunostaining	34284
@NP	all groups	34302
@NP	the rat-specific low-affinity nerve growth factor receptor mp75	34317
@NP	GFAP and GFP + OECs	34395
@NP	GFAP	34395
@NP	GFP + OECs	34404
@NP	endogenous cells	34423
@NP	p75	34451
@NP	areas with OECs within the lesion site -LRB- Fig. 4B , D -RRB-	34458
@NP	areas	34458
@NP	OECs within the lesion site -LRB- Fig. 4B , D -RRB-	34469
@NP	OECs	34469
@NP	the lesion site -LRB- Fig. 4B , D -RRB-	34481
@NP	the lesion site	34481
@NP	Fig. 4B , D	34498
@NP	Fig. 4B	34498
@NP	D	34506
@NP	the injection points in LP - -LRB- Fig. 4A -RRB-	34534
@NP	the injection points	34534
@NP	LP	34558
@NP	Fig. 4A	34563
@NP	OBtreated rats -LRB- Fig. 4C -RRB-	34576
@NP	OBtreated rats	34576
@NP	Fig. 4C	34592
@NP	We	34602
@NP	these rat p75	34632
@NP	cells	34647
@NP	SCs	34656
@NP	other markers	34666
@NP	rat SCs -LRB- Chernousov et al. , 1999 ; Ramer et al. , 2004b -RRB-	34684
@NP	rat SCs	34684
@NP	Chernousov	34693
@NP	et al. , 1999 ; Ramer et al. , 2004b	34704
@NP	et al.	34704
@NP	1999 ; Ramer et al.	34712
@NP	1999	34712
@NP	Ramer et al.	34718
@NP	Ramer	34718
@NP	et al.	34724
@NP	2004b	34732
@NP	Ingression of Schwann cells into the spinal cord parenchyma	34740
@NP	Ingression	34740
@NP	Schwann cells into the spinal cord parenchyma	34754
@NP	Schwann cells	34754
@NP	the spinal cord parenchyma	34773
@NP	the GFAP lesion boundary	34815
@NP	OEC-treated groups , in which Schwann cells were found maximally at 350 µm	34868
@NP	OEC-treated groups	34868
@NP	Schwann cells	34897
@NP	350 µm	34935
@NP	the lesion site	34947
@NP	Schwann cell infiltration	34964
@NP	control animals -LRB- Fig. 4E -RRB-	35009
@NP	control animals	35009
@NP	Fig. 4E	35026
@NP	80 µm of the lesion boundary	35064
@NP	80 µm	35064
@NP	the lesion boundary	35073
@NP	SCs that infiltrated after OEC transplantation	35094
@NP	SCs	35094
@NP	OEC transplantation	35121
@NP	LP -LRB- Fig. 4B -RRB- and OB -LRB- Fig. 4C -RRB- OECs ,	35167
@NP	LP	35167
@NP	Fig. 4B	35171
@NP	OB -LRB- Fig. 4C -RRB- OECs	35184
@NP	OB	35184
@NP	Fig. 4C	35188
@NP	OECs	35197
@NP	CNS astrocytes -LRB- Fig. 4B , D -RRB-	35219
@NP	CNS astrocytes	35219
@NP	Fig. 4B , D	35235
@NP	Fig. 4B	35235
@NP	D	35243
@NP	This	35247
@NP	some of the proregenerative effects of LP and OB OEC transplantation	35266
@NP	some	35266
@NP	the proregenerative effects of LP and OB OEC transplantation	35274
@NP	the proregenerative effects	35274
@NP	LP and OB OEC transplantation	35305
@NP	part	35359
@NP	their ability to recruit , activate , or cooperate with endogenous Schwann cells	35368
@NP	endogenous Schwann cells	35422
@NP	Axonal sprouting into the lesion site	35448
@NP	Axonal	35448
@NP	the lesion site	35470
@NP	rats	35502
@NP	LP OEC animals	35540
@NP	The results	35555
@NP	distinct biological differences in the ability of OB and LP OECs	35582
@NP	distinct biological differences	35582
@NP	the ability of OB and LP OECs	35617
@NP	the ability	35617
@NP	OB and LP OECs	35632
@NP	repair	35658
@NP	We	35666
@NP	these findings	35683
@NP	-LRB- 1 -RRB- differences in axonal outgrowth	35719
@NP	differences	35723
@NP	axonal outgrowth	35738
@NP	-LRB- 2 -RRB- differences in angiogenesis	35756
@NP	differences	35760
@NP	angiogenesis	35775
@NP	differences	35797
@NP	the directionality of these parameters in relation to transplanted cells	35812
@NP	the directionality	35812
@NP	these parameters in relation to transplanted cells	35834
@NP	these parameters	35834
@NP	relation to transplanted cells	35854
@NP	relation	35854
@NP	transplanted cells	35866
@NP	This	35886
@NP	us	35903
@NP	factors	35936
@NP	an SCI lesion area	35958
@NP	repair	35999
@NP	the lesion site	36017
@NP	the location of the OECs	36044
@NP	the location	36044
@NP	the OECs	36060
@NP	repair and regeneration parameters	36091
@NP	Large-caliber axons expressing NF	36127
@NP	Large-caliber axons	36127
@NP	NF	36158
@NP	differences	36174
@NP	degree	36189
@NP	both	36222
@NP	LP -LRB- Fig. 5A , B -RRB- or OB -LRB- Fig. 5C , D -RRB- OECs	36235
@NP	LP -LRB- Fig. 5A , B -RRB-	36235
@NP	LP	36235
@NP	Fig. 5A , B	36239
@NP	Fig. 5A	36239
@NP	B	36247
@NP	OB -LRB- Fig. 5C , D -RRB- OECs	36253
@NP	OB	36253
@NP	Fig. 5C , D	36257
@NP	Fig. 5C	36257
@NP	D	36265
@NP	OECs	36268
@NP	introduction	36303
@NP	all animals	36347
@NP	some axons	36360
@NP	cavity-free areas of the lesion site	36385
@NP	cavity-free areas	36385
@NP	the lesion site	36406
@NP	cell delivery approach	36437
@NP	the distribution of axon growth	36465
@NP	the distribution	36465
@NP	axon growth	36485
@NP	treatment groups	36524
@NP	the lesion site	36564
@NP	rats that received direct transplants of LP and OB OECs	36584
@NP	rats	36584
@NP	direct transplants of LP and OB OECs	36603
@NP	direct transplants	36603
@NP	LP and OB OECs	36625
@NP	axonal growth	36641
@NP	the caudal lesion boundary -LRB- four of four for each group -RRB-	36682
@NP	the caudal lesion boundary	36682
@NP	four of four for each group	36710
@NP	four	36710
@NP	four	36718
@NP	each group	36727
@NP	Fig. 5B , D	36740
@NP	Fig. 5B	36740
@NP	D	36748
@NP	addition	36755
@NP	some NF + axons	36774
@NP	some NF	36774
@NP	axons	36783
@NP	the lesion site	36809
@NP	direct transplant groups	36833
@NP	zones devoid of NF + axons	36859
@NP	zones	36859
@NP	NF + axons	36875
@NP	NF	36875
@NP	axons	36879
@NP	the GFAP-immunoreactive border	36912
@NP	LP direct , n = 3 of 4 ; OB direct , n = 4 of 4	36944
@NP	LP direct	36944
@NP	LP	36944
@NP	direct	36947
@NP	n = 3 of 4 ; OB direct	36955
@NP	n = 3 of 4	36955
@NP	n = 3	36955
@NP	n	36955
@NP	3	36959
@NP	4	36964
@NP	OB direct	36967
@NP	OB	36967
@NP	direct	36970
@NP	n = 4 of 4	36978
@NP	n = 4	36978
@NP	n	36978
@NP	4	36982
@NP	4	36987
@NP	Rats that received rostrocaudal LPOEC transplants -LRB- Fig. 5A -RRB-	36991
@NP	Rats that received rostrocaudal LPOEC transplants	36991
@NP	Rats	36991
@NP	rostrocaudal LPOEC transplants	37010
@NP	Fig. 5A	37042
@NP	a higher incidence of NF + axons within the lesion site	37064
@NP	a higher incidence	37064
@NP	NF + axons within the lesion site	37086
@NP	NF + axons	37086
@NP	the lesion site	37103
@NP	all other groups	37133
@NP	NF + reactivity	37164
@NP	NF	37164
@NP	reactivity	37168
@NP	the lesion site	37207
@NP	the astrocytic border	37237
@NP	rats that received LP or OB OECs transplanted directly into the lesion	37274
@NP	rats	37274
@NP	LP or OB OECs transplanted directly into the lesion	37293
@NP	LP or OB OECs	37293
@NP	the lesion	37334
@NP	Rats that received rostrocaudal OB OEC transplants	37346
@NP	Rats	37346
@NP	rostrocaudal OB OEC transplants	37365
@NP	the lowest incidence of NF	37410
@NP	the lowest incidence	37410
@NP	NF	37434
@NP	reactivity within the lesion site -LRB- n = 4 of 4 -RRB- -LRB- Fig. 5C -RRB-	37438
@NP	reactivity	37438
@NP	the lesion site -LRB- n = 4 of 4 -RRB- -LRB- Fig. 5C -RRB-	37456
@NP	the lesion site -LRB- n = 4 of 4 -RRB-	37456
@NP	the lesion site	37456
@NP	n = 4 of 4	37473
@NP	n = 4	37473
@NP	n	37473
@NP	4	37477
@NP	4	37482
@NP	Fig. 5C	37486
@NP	the differences in axon growth	37521
@NP	the differences	37521
@NP	axon growth	37540
@NP	the lesion site	37559
@NP	all treatment groups	37578
@NP	densitometry of NF + pixels	37600
@NP	densitometry	37600
@NP	NF + pixels	37616
@NP	NF	37616
@NP	pixels	37620
@NP	the GFAP-reactive border	37654
@NP	NF + pixels within this area -LRB- Fig. 5E -RRB-	37692
@NP	NF + pixels	37692
@NP	this area -LRB- Fig. 5E -RRB-	37710
@NP	this area	37710
@NP	Fig. 5E	37721
@NP	A significant increase in growth within the lesion	37731
@NP	A significant increase	37731
@NP	growth within the lesion	37757
@NP	growth	37757
@NP	the lesion	37771
@NP	rostrocaudal transplantation of LP OECs	37798
@NP	rostrocaudal transplantation	37798
@NP	LP OECs	37830
@NP	all other groups -LRB- n = 4 ; p ≤ 0.001 , all groups -RRB- -LRB- Fig. 5E -RRB-	37852
@NP	all other groups -LRB- n = 4 ; p ≤ 0.001 , all groups -RRB-	37852
@NP	all other groups	37852
@NP	n = 4 ; p ≤ 0.001 , all groups	37870
@NP	n = 4 ; p ≤ 0.001 , all	37870
@NP	n = 4	37870
@NP	n	37870
@NP	4	37872
@NP	p ≤ 0.001 , all	37875
@NP	p	37875
@NP	≤ 0.001	37876
@NP	groups	37888
@NP	Fig. 5E	37897
@NP	rats that received OB OECs directly at the lesion site	37916
@NP	rats	37916
@NP	OB OECs	37935
@NP	the lesion site	37955
@NP	significantly more NF + axons	37984
@NP	significantly more NF	37984
@NP	axons	38007
@NP	the lesion	38020
@NP	rostrocaudal OB OEC transplants -LRB- n = 4 , all groups ; p ≤ 0.05 -RRB-	38045
@NP	rostrocaudal OB OEC transplants	38045
@NP	n = 4 , all groups ; p ≤ 0.05	38078
@NP	n = 4	38078
@NP	n	38078
@NP	4	38082
@NP	groups ; p ≤ 0.05	38089
@NP	groups	38089
@NP	p ≤ 0.05	38097
@NP	p	38097
@NP	≤ 0.05	38099
@NP	These results	38108
@NP	cell type and delivery method	38135
@NP	cell type	38135
@NP	delivery method	38149
@NP	the pattern of growth of sprouting axons	38191
@NP	the pattern	38191
@NP	growth of sprouting axons	38206
@NP	growth	38206
@NP	axons	38226
@NP	their ability	38250
@NP	the lesion site	38277
@NP	Directional angiogenesis	38294
@NP	OEC treatment	38334
@NP	Much of the axonal outgrowth	38348
@NP	Much	38348
@NP	the axonal outgrowth	38356
@NP	rats treated by rostrocaudal LP OEC transplantation -LRB- Fig. 5A -RRB-	38409
@NP	rats	38409
@NP	rostrocaudal LP OEC transplantation -LRB- Fig. 5A -RRB-	38425
@NP	rostrocaudal LP OEC transplantation	38425
@NP	Fig. 5A	38462
@NP	the lesion site	38497
@NP	We	38514
@NP	angiogenesis in the lesion site	38544
@NP	angiogenesis	38544
@NP	the lesion site	38560
@NP	LP OEC transplantation	38589
@NP	many axons	38622
@NP	blood vessel laminas -LRB- Ramer et al. , 2004b -RRB-	38646
@NP	blood vessel laminas	38646
@NP	Ramer	38668
@NP	et al. , 2004b	38674
@NP	et al.	38674
@NP	2004b	38682
@NP	an angiogenic response	38703
@NP	axon growth	38742
@NP	contusive injury -LRB- Loy et al. , 2002 -RRB-	38787
@NP	contusive injury	38787
@NP	Loy	38805
@NP	et al. , 2002	38809
@NP	et al.	38809
@NP	2002	38817
@NP	it	38835
@NP	the direction of axon growth	38855
@NP	the direction	38855
@NP	axon growth	38872
@NP	the direction of blood vessel growth	38902
@NP	the direction	38902
@NP	blood vessel growth	38919
@NP	this	38944
@NP	different transplantation strategies	38973
@NP	ing axons	39045
@NP	the spinal cord instead of becoming entangled at the lesion site	39085
@NP	the spinal cord	39085
@NP	the lesion site	39134
@NP	the extent and directionality of blood vessel growth	39161
@NP	the extent and directionality	39161
@NP	blood vessel growth	39194
@NP	anti-RECA and GFAP detection	39215
@NP	anti-RECA	39215
@NP	GFAP detection	39229
@NP	blood vessels	39266
@NP	the lesion site -LRB- Fig. 6A -- E -RRB-	39298
@NP	the lesion site	39298
@NP	Fig. 6A -- E	39315
@NP	Fig. 6A	39315
@NP	E	39323
@NP	directionality	39338
@NP	montages of Z-stacked images of RECA-immunoreactive endothelia	39354
@NP	montages	39354
@NP	Z-stacked images of RECA-immunoreactive endothelia	39366
@NP	Z-stacked images	39366
@NP	RECA-immunoreactive endothelia	39386
@NP	a threshold intensity -LRB- applied within and across groups -RRB-	39431
@NP	a threshold intensity	39431
@NP	groups	39480
@NP	a best-fit line along their linear axis	39511
@NP	a best-fit line	39511
@NP	their linear axis	39533
@NP	an algorithm	39558
@NP	Matlab	39585
@NP	their direction of growth -LRB- Fig. 6F -RRB-	39606
@NP	their direction	39606
@NP	growth -LRB- Fig. 6F -RRB-	39625
@NP	growth	39625
@NP	Fig. 6F	39633
@NP	The predicted intersection points of lines	39643
@NP	The predicted intersection points	39643
@NP	lines	39680
@NP	contour maps of most likely endothelial convergence -LRB- Fig. 6G -- K -RRB-	39714
@NP	contour maps	39714
@NP	most likely endothelial convergence -LRB- Fig. 6G -- K -RRB-	39730
@NP	most likely endothelial convergence	39730
@NP	Fig. 6G -- K	39767
@NP	Fig. 6G	39767
@NP	K	39775
@NP	The density of intersections within the lesion site	39779
@NP	The density	39779
@NP	intersections within the lesion site	39794
@NP	intersections	39794
@NP	the lesion site	39815
@NP	a baseline of intersections	39849
@NP	a baseline	39849
@NP	intersections	39863
@NP	the same lesion area , randomly placed throughout the same spinal cord	39884
@NP	the same lesion area	39884
@NP	the same spinal cord	39933
@NP	This	39955
@NP	a measure	39969
@NP	the extent of directionality of blood vessels toward the lesion site	39982
@NP	the extent	39982
@NP	directionality of blood vessels toward the lesion site	39996
@NP	directionality	39996
@NP	blood vessels toward the lesion site	40014
@NP	blood vessels	40014
@NP	the lesion site	40035
@NP	lesion area	40067
@NP	number of blood vessels	40087
@NP	number	40087
@NP	blood vessels	40097
@NP	Scores greater than zero	40112
@NP	Scores	40112
@NP	zero	40132
@NP	directionality of blood vessels toward the lesion site	40156
@NP	directionality	40156
@NP	blood vessels toward the lesion site	40174
@NP	blood vessels	40174
@NP	the lesion site	40195
@NP	all OEC-treated rats	40215
@NP	there	40237
@NP	significantly greater numbers of blood vessels	40248
@NP	significantly greater numbers	40248
@NP	blood vessels	40281
@NP	control animals -LRB- Table 1 -RRB-	40303
@NP	control animals	40303
@NP	Table 1	40320
@NP	there	40339
@NP	a significant and 1.9-fold increase	40349
@NP	directionality	40389
@NP	blood vessel growth	40407
@NP	the lesion site	40434
@NP	rats	40453
@NP	OEC transplants	40472
@NP	the random endothelial growth in control animals	40502
@NP	the random endothelial growth	40502
@NP	control animals	40535
@NP	Table 1	40552
@NP	Rats that were directly transplanted with OB OECs	40562
@NP	Rats	40562
@NP	OB OECs	40604
@NP	the most significant blood vessel growth	40625
@NP	the lesion site	40682
@NP	Vascularization and enhanced regeneration	40699
@NP	Vascularization	40699
@NP	enhanced regeneration	40719
@NP	the peripheral nervous system -LRB- Hobson et al. , 2000 -RRB-	40769
@NP	the peripheral nervous system	40769
@NP	Hobson	40800
@NP	et al. , 2000	40807
@NP	et al.	40807
@NP	2000	40815
@NP	the increase in blood vessels	40826
@NP	the increase	40826
@NP	blood vessels	40842
@NP	their direction of growth in all OEC-treated rats	40860
@NP	their direction	40860
@NP	growth in all OEC-treated rats	40879
@NP	growth	40879
@NP	all OEC-treated rats	40889
@NP	directed axon growth	40920
@NP	the CNS	40948
@NP	Autotomy	40957
@NP	OB OEC	40980
@NP	elevated by LP OEC transplantation Transplantation of either LP or OB OECs	40991
@NP	elevated	40991
@NP	LP OEC transplantation Transplantation of either LP or OB OECs	41003
@NP	LP OEC transplantation Transplantation	41003
@NP	either LP or OB OECs	41045
@NP	LP	41052
@NP	OB OECs	41058
@NP	the enhanced growth of NF axons within the lesion site	41078
@NP	the enhanced growth	41078
@NP	NF axons within the lesion site	41101
@NP	NF axons	41101
@NP	the lesion site	41118
@NP	it	41144
@NP	these axons	41166
@NP	functional connections	41183
@NP	target neurons	41249
@NP	27 d after lesion and transplantation	41268
@NP	27 d	41268
@NP	lesion and transplantation	41279
@NP	autotomy	41307
@NP	some rats	41332
@NP	we	41346
@NP	the degree of autotomy	41377
@NP	the degree	41377
@NP	autotomy	41391
@NP	groups	41415
@NP	this measure	41430
@NP	an admittedly negative behavioral readout for changes in functional connectivity	41458
@NP	an admittedly negative behavioral readout	41458
@NP	changes in functional connectivity	41504
@NP	changes	41504
@NP	functional connectivity	41515
@NP	Autotomy	41540
@NP	the self-attack	41552
@NP	a -LRB- partially -RRB-	41571
@NP	limb	41596
@NP	the anesthetic limb	41662
@NP	digit amputation -LRB- Kauppila , 1998 ; Zimmermann , 2001 -RRB-	41707
@NP	digit amputation	41707
@NP	Kauppila , 1998 ; Zimmermann , 2001	41725
@NP	Kauppila	41725
@NP	1998 ; Zimmermann	41735
@NP	1998	41735
@NP	Zimmermann	41741
@NP	2001	41753
@NP	Autotomy	41760
@NP	the methods	41786
@NP	Wall -LRB- 1979 -RRB-	41811
@NP	Wall	41811
@NP	1979	41817
@NP	a total of three points	41833
@NP	a total	41833
@NP	three points	41844
@NP	the attack of each digit	41874
@NP	the attack	41874
@NP	each digit	41888
@NP	1 point for nail removal	41900
@NP	1 point	41900
@NP	nail removal	41912
@NP	2 points for amputation up to the first knuckle	41926
@NP	2 points	41926
@NP	amputation up to the first knuckle	41939
@NP	amputation	41939
@NP	the first knuckle	41956
@NP	3 points for total digit removal	41979
@NP	3 points	41979
@NP	total digit removal	41992
@NP	a total of 15 possible points for each paw -LRB- Fig. 7A -RRB-	42017
@NP	a total	42017
@NP	15 possible points for each paw -LRB- Fig. 7A -RRB-	42028
@NP	15 possible points	42028
@NP	each paw -LRB- Fig. 7A -RRB-	42051
@NP	each paw	42051
@NP	Fig. 7A	42061
@NP	each rat	42075
@NP	the affected right hindpaw	42085
@NP	the left hindpaw , which served as an internal control	42134
@NP	the left hindpaw	42134
@NP	an internal control	42168
@NP	Rats that received direct transplants of LP OECs -LRB- n 4 -RRB-	42189
@NP	Rats that received direct transplants of LP OECs	42189
@NP	Rats	42189
@NP	direct transplants of LP OECs	42208
@NP	direct transplants	42208
@NP	LP OECs	42230
@NP	n 4	42239
@NP	the greatest autotomy scores	42248
@NP	either control -LRB- n = 4 -RRB-	42305
@NP	either control	42305
@NP	n	42321
@NP	4	42325
@NP	OB rats -LRB- n = 5 ; p ≤ 0.05 and p ≤ 0.01 -RRB- -LRB- Fig. 7B -RRB-	42353
@NP	OB rats -LRB- n = 5 ; p ≤ 0.05 and p ≤ 0.01 -RRB-	42353
@NP	OB rats	42353
@NP	n = 5 ; p ≤ 0.05 and p ≤ 0.01	42362
@NP	n = 5 ; p ≤ 0.05	42362
@NP	n = 5	42362
@NP	n	42362
@NP	5	42366
@NP	p ≤ 0.05	42369
@NP	p	42369
@NP	≤ 0.05	42371
@NP	p ≤ 0.01	42382
@NP	p	42382
@NP	≤ 0.01	42384
@NP	Fig. 7B	42393
@NP	transplanted OB OEC rats	42418
@NP	lower autotomy	42456
@NP	transplanted LP rats	42491
@NP	control rats -LRB- n = 4 , 5 , 5 ; p ≤ 0.05 and p ≤ 0.05 , respectively -RRB-	42516
@NP	control rats	42516
@NP	n = 4 , 5 , 5 ; p ≤ 0.05 and p ≤ 0.05 , respectively	42530
@NP	n = 4	42530
@NP	n	42530
@NP	4	42534
@NP	5 , 5 ; p ≤ 0.05	42537
@NP	5 , 5	42537
@NP	5	42537
@NP	5	42540
@NP	p ≤ 0.05	42543
@NP	p	42543
@NP	≤ 0.05	42545
@NP	p ≤ 0.05 , respectively	42556
@NP	p	42556
@NP	≤ 0.05	42558
@NP	Fig. 7B	42581
@NP	LP OEC transplantation	42591
@NP	autotomy	42629
@NP	injection paradigm	42652
@NP	the incidence -LRB- OB , 2 of 8 rats ; LP , 6 of 10 rats -RRB-	42680
@NP	the incidence	42680
@NP	OB , 2 of 8 rats ; LP , 6 of 10 rats	42695
@NP	OB	42695
@NP	2 of 8 rats ; LP , 6 of 10 rats	42699
@NP	2 of 8 rats	42699
@NP	2	42699
@NP	8 rats	42704
@NP	LP , 6 of 10 rats	42712
@NP	LP	42712
@NP	6 of 10 rats	42716
@NP	6	42716
@NP	10 rats	42721
@NP	extent of autotomy	42734
@NP	extent	42734
@NP	autotomy	42744
@NP	92 % less autotomy in OB rats	42754
@NP	92 % less autotomy	42754
@NP	92 %	42754
@NP	OB rats	42775
@NP	OB-treated rats	42796
@NP	TH	42826
@NP	subP	42831
@NP	CGRPpositive axons	42842
@NP	LP or OB OEC transplantation	42893
@NP	LP and OB OECs	42938
@NP	that	42999
@NP	we	43034
@NP	the pattern	43045
@NP	axon outgrowth from dorsal root afferents as well as different descending tracts	43060
@NP	axon outgrowth from dorsal root afferents	43060
@NP	axon outgrowth	43060
@NP	dorsal root afferents	43080
@NP	different descending tracts	43113
@NP	We	43142
@NP	LP OEC transplantation	43172
@NP	the growth of 5-HT	43206
@NP	the growth	43206
@NP	5-HT	43220
@NP	TH + axons	43230
@NP	TH	43230
@NP	axons	43234
@NP	some growth of dorsal root afferents	43252
@NP	some growth	43252
@NP	dorsal root afferents	43267
@NP	CGRP	43300
@NP	+	43304
@NP	subP	43309
@NP	+	43313
@NP	Ramer et al. , 2004b	43316
@NP	Ramer	43316
@NP	et al.	43322
@NP	2004b	43330
@NP	We	43338
@NP	horizontal sections	43349
@NP	the lesion site	43377
@NP	the presence	43397
@NP	these axonal subpopulations	43413
@NP	the GFAP + border	43447
@NP	the boundaries of the lesion site	43476
@NP	the boundaries	43476
@NP	the lesion site	43494
@NP	Montaged , Z-stacked sections	43511
@NP	Montaged	43511
@NP	Z-stacked sections	43521
@NP	the total number of positive pixels	43558
@NP	the total number	43558
@NP	positive pixels	43578
@NP	the lesion site	43601
@NP	areas 0.5 and 1 mm rostral and caudal	43636
@NP	areas 0.5 and 1	43636
@NP	mm rostral and caudal	43652
@NP	the lesion	43677
@NP	We	43689
@NP	the presence of different axonal subtypes	43709
@NP	the presence	43709
@NP	different axonal subtypes	43725
@NP	24 h	43754
@NP	lesion and transplantation	43765
@NP	all axons tested	43807
@NP	all axons	43807
@NP	the lesion site	43841
@NP	the rostral	43890
@NP	caudal lesion boundaries	43906
@NP	supplemental Fig. 2 , available at www.jneurosci.org as supplemental material	43932
@NP	supplemental Fig. 2 , available at www.jneurosci.org	43932
@NP	supplemental Fig.	43932
@NP	2	43950
@NP	www.jneurosci.org	43966
@NP	supplemental material	43987
@NP	28 d	44014
@NP	rats that received LP OECs -LRB- Fig. 8A -RRB- and OB OECs -LRB- Fig. 8B -RRB-	44023
@NP	rats	44023
@NP	LP OECs -LRB- Fig. 8A -RRB- and OB OECs -LRB- Fig. 8B -RRB-	44042
@NP	LP OECs -LRB- Fig. 8A -RRB-	44042
@NP	LP OECs	44042
@NP	Fig. 8A	44051
@NP	OB OECs -LRB- Fig. 8B -RRB-	44064
@NP	OB OECs	44064
@NP	Fig. 8B	44073
@NP	subP-positive axons	44083
@NP	the lesion site	44121
@NP	caudal	44156
@NP	the lesion site	44166
@NP	No significant differences in axonal outgrowth of subtypes	44183
@NP	No significant differences	44183
@NP	axonal outgrowth of subtypes	44213
@NP	axonal outgrowth	44213
@NP	subtypes	44233
@NP	direct and rostrocaudally transplanted rats within LP or OB OEC treatment groups	44264
@NP	direct and rostrocaudally transplanted rats	44264
@NP	LP or OB OEC treatment groups	44315
@NP	both sets of data for each OEC subtype	44350
@NP	both sets	44350
@NP	data for each OEC subtype	44363
@NP	data	44363
@NP	each OEC subtype	44372
@NP	OB-transplanted rats	44420
@NP	subP reactivity	44442
@NP	rostral	44468
@NP	the lesion site -LRB- Fig. 8B , inset -RRB-	44479
@NP	the lesion site	44479
@NP	Fig. 8B , inset	44496
@NP	Fig. 8B	44496
@NP	less reactivity	44521
@NP	this location in LP OEC -LRB- Fig. 8A , inset -RRB- transplanted rats	44553
@NP	this location	44553
@NP	LP OEC -LRB- Fig. 8A , inset -RRB- transplanted rats	44570
@NP	LP OEC -LRB- Fig. 8A , inset -RRB-	44570
@NP	LP OEC	44570
@NP	Fig. 8A , inset	44578
@NP	Fig. 8A	44578
@NP	rats	44607
@NP	subP-positive axons	44613
@NP	all points	44665
@NP	rats	44679
@NP	OB OECs	44698
@NP	LP OECs -LRB- n = 4 each group ; p ≤ 0.05 all levels -RRB- -LRB- Fig. 8C -RRB-	44720
@NP	LP OECs -LRB- n = 4 each group ; p ≤ 0.05 all levels -RRB-	44720
@NP	LP OECs	44720
@NP	n = 4 each group ; p ≤ 0.05 all levels	44729
@NP	n = 4 each group ; p ≤ 0.05	44729
@NP	n = 4 each group	44729
@NP	n	44729
@NP	= 4 each group	44731
@NP	4	44733
@NP	p ≤ 0.05	44747
@NP	p	44747
@NP	≤ 0.05	44750
@NP	all levels	44756
@NP	Fig. 8C	44769
@NP	This	44779
@NP	OB OECs	44798
@NP	LP OECs	44830
@NP	the sprouting of subP-positive axons after injury	44851
@NP	the sprouting	44851
@NP	subP-positive axons after injury	44868
@NP	subP-positive axons	44868
@NP	injury	44894
@NP	CGRP-positive nociceptive/temperature responsive afferents	44902
@NP	nociceptive/temperature	44916
@NP	LP OEC transplantation -LRB- Ramer et al. , 2004b -RRB-	44984
@NP	LP OEC transplantation	44984
@NP	Ramer	45008
@NP	et al. , 2004b	45014
@NP	et al.	45014
@NP	2004b	45022
@NP	their sprouting	45034
@NP	their	45034
@NP	pain sensation	45063
@NP	SCI -LRB- Jang et al. , 2004 -RRB-	45084
@NP	SCI	45084
@NP	Jang	45089
@NP	et al. , 2004	45094
@NP	et al.	45094
@NP	2004	45102
@NP	Detection	45109
@NP	CGRP-positive axons	45122
@NP	rats	45145
@NP	LP OECs -LRB- Fig. 8D -RRB- and OB OECs -LRB- Fig. 8E -RRB-	45164
@NP	LP OECs -LRB- Fig. 8D -RRB-	45164
@NP	LP OECs	45164
@NP	Fig. 8D	45173
@NP	OB OECs -LRB- Fig. 8E -RRB-	45186
@NP	OB OECs	45186
@NP	Fig. 8E	45195
@NP	patterns	45231
@NP	groups	45248
@NP	LP OECs	45265
@NP	0.5 mmrostral	45302
@NP	the lesion site -LRB- n 4 each group -RRB- -LRB- Fig. 8F -RRB-	45318
@NP	the lesion site -LRB- n 4 each group -RRB-	45318
@NP	the lesion site	45318
@NP	n 4 each group	45335
@NP	n 4	45335
@NP	each group	45340
@NP	Fig. 8F	45353
@NP	the rostral lesion border -LRB- Fig. 8D , inset , F -RRB-	45402
@NP	the rostral lesion border	45402
@NP	Fig. 8D	45429
@NP	inset	45438
@NP	F	45445
@NP	Both types of OEC did	45449
@NP	Both types	45449
@NP	OEC did	45463
@NP	OEC	45463
@NP	the growth of CGRP-positive axons over control animals	45489
@NP	the growth	45489
@NP	CGRP-positive axons over control animals	45503
@NP	CGRP-positive axons	45503
@NP	control animals	45528
@NP	the lesion site	45565
@NP	no sparing of CGRPpositive axons	45591
@NP	no sparing	45591
@NP	CGRPpositive axons	45605
@NP	24 h	45639
@NP	lesion	45650
@NP	No significant differences in CGRPpositive sprouting	45658
@NP	No significant differences	45658
@NP	CGRPpositive sprouting	45688
@NP	CGRPpositive	45688
@NP	direct and rostrocaudally transplanted rats	45733
@NP	raphespinal 5-HTpositive axons	45791
@NP	both LP - and OB-treated rats -LRB- Fig. 8G , H -RRB-	45842
@NP	both LP	45842
@NP	OB-treated rats	45855
@NP	Fig. 8G , H	45872
@NP	Fig. 8G	45872
@NP	H	45880
@NP	CGRP + and subP	45915
@NP	CGRP	45915
@NP	and subP	45921
@NP	no significant differences	45942
@NP	transplant groups -LRB- n = 4 for all groups -RRB- -LRB- Fig. 8I -RRB-	45991
@NP	transplant groups -LRB- n = 4 for all groups -RRB-	45991
@NP	transplant groups	45991
@NP	n = 4 for all groups	46010
@NP	n = 4	46010
@NP	n	46010
@NP	4	46014
@NP	all groups	46020
@NP	Fig. 8I	46033
@NP	5-HT-positive axons	46043
@NP	the lesion site -LRB- Fig. 8G , H , insets -RRB-	46122
@NP	the lesion site	46122
@NP	Fig. 8G , H , insets	46139
@NP	Fig. 8G	46139
@NP	H	46147
@NP	insets	46150
@NP	contrast	46162
@NP	detection of TH	46172
@NP	detection	46172
@NP	TH	46185
@NP	significantly more TH-positive axons rostral	46197
@NP	the lesion site	46256
@NP	rats that received LP OECs compared with OB OECs -LRB- Fig. 8J -- L -RRB-	46275
@NP	rats	46275
@NP	LP OECs	46294
@NP	OB OECs -LRB- Fig. 8J -- L -RRB-	46316
@NP	OB OECs	46316
@NP	Fig. 8J -- L	46325
@NP	Fig. 8J	46325
@NP	L	46333
@NP	This	46337
@NP	the rostral lesion boundary	46370
@NP	THpositive axons	46408
@NP	LPtransplanted -LRB- Fig. 8J , inset -RRB-	46443
@NP	LPtransplanted	46443
@NP	Fig. 8J , inset	46459
@NP	Fig. 8J	46459
@NP	OB-transplanted -LRB- Fig. 8I , inset -RRB- rats	46489
@NP	OB-transplanted -LRB- Fig. 8I , inset -RRB-	46489
@NP	OB-transplanted	46489
@NP	Fig. 8I , inset	46506
@NP	Fig. 8I	46506
@NP	rats	46522
@NP	neither 5-HT	46536
@NP	TH-positive axons	46554
@NP	the lesion site 24 h	46592
@NP	lesion , the transplanted LP and OB OECs	46619
@NP	lesion	46619
@NP	the transplanted LP	46627
@NP	OB OECs	46651
@NP	growth of these axon subtypes	46674
@NP	growth	46674
@NP	these axon subtypes	46684
@NP	Discussion OECs	46705
@NP	prime candidates	46746
@NP	cell-based therapies	46767
@NP	the injured CNS -LRB- Lakatos and Franklin , 2002 -RRB-	46798
@NP	the injured CNS	46798
@NP	Lakatos and Franklin , 2002	46815
@NP	Lakatos	46815
@NP	Franklin , 2002	46827
@NP	Franklin	46827
@NP	2002	46837
@NP	some OB OEC transplantation experiments	46852
@NP	different degrees of functional recovery	46907
@NP	different degrees	46907
@NP	functional recovery	46928
@NP	SCI	46953
@NP	Ramon-Cueto	46958
@NP	et al. , 2000 ; Keyvan - Fouladi et al. , 2003 ; Garcia-Alias et al. , 2004	46970
@NP	et al.	46970
@NP	2000 ; Keyvan - Fouladi et al. , 2003 ; Garcia-Alias et al.	46978
@NP	2000 ; Keyvan	46978
@NP	2000	46978
@NP	Keyvan	46984
@NP	Fouladi et al. , 2003	46992
@NP	Fouladi	46992
@NP	et al. , 2003	47000
@NP	et al.	47000
@NP	2003	47008
@NP	Garcia-Alias et al.	47014
@NP	Garcia-Alias	47014
@NP	et al.	47027
@NP	2004	47035
@NP	cell preparations containing LP OECs	47042
@NP	cell preparations	47042
@NP	LP OECs	47071
@NP	human SCI	47119
@NP	the assumption	47138
@NP	LP and OB OECs	47158
@NP	Senior , 2002 ; Huang et al. , 2003 ; Rabinovich et al. , 2003	47202
@NP	Senior	47202
@NP	2002 ; Huang et al. , 2003 ; Rabinovich et al.	47210
@NP	2002	47210
@NP	Huang et al. , 2003 ; Rabinovich et al.	47216
@NP	Huang	47216
@NP	et al. , 2003 ; Rabinovich et al.	47222
@NP	et al. , 2003	47222
@NP	et al.	47222
@NP	2003	47230
@NP	Rabinovich et al.	47236
@NP	Rabinovich	47236
@NP	et al.	47247
@NP	2003	47255
@NP	both mechanistic and clinical reasons	47266
@NP	we	47305
@NP	the effect of transplanting OB and LP OECs into lesioned spinal cord	47322
@NP	the effect	47322
@NP	OB and LP OECs	47350
@NP	lesioned spinal cord	47370
@NP	they	47411
@NP	significantly different regeneration outcomes	47424
@NP	OB OECs	47485
@NP	LP OECs	47494
@NP	lesion site and cavity area and increase sprouting of NF	47511
@NP	lesion site and cavity area and increase	47511
@NP	NF	47565
@NP	+ and TH + axons	47567
@NP	and TH	47568
@NP	axons	47576
@NP	autotomy	47601
@NP	contrast	47614
@NP	OB OEC transplantation	47624
@NP	lesion site area and cavity formation	47657
@NP	lesion site area	47657
@NP	cavity formation	47678
@NP	subP + axons	47718
@NP	subP	47718
@NP	axons	47724
@NP	the greatest directional angiogenesis	47744
@NP	addition	47786
@NP	rostrocaudal compared with direct transplantation	47796
@NP	rostrocaudal	47796
@NP	direct transplantation	47823
@NP	LP and OB OECs	47860
@NP	different abilities to migrate	47880
@NP	cell delivery method	47920
@NP	astrogliosis , NF + sprouting , and cavity formation	47963
@NP	astrogliosis , NF + sprouting	47963
@NP	astrogliosis , NF	47963
@NP	astrogliosis	47963
@NP	NF	47977
@NP	sprouting	47981
@NP	cavity formation	47996
@NP	The morphological and antigenic profiles of LP and OB OECs in culture	48014
@NP	The morphological and antigenic profiles	48014
@NP	LP and OB OECs in culture	48058
@NP	LP and OB OECs	48058
@NP	culture	48076
@NP	Fig. 1	48085
@NP	OEC types	48111
@NP	their differing roles in PNS and CNS environments in the olfactory system	48148
@NP	their differing roles	48148
@NP	PNS and CNS environments	48173
@NP	the olfactory system	48201
@NP	expansion capacities in vitro	48227
@NP	expansion capacities	48227
@NP	vitro	48251
@NP	LP and OB OECs	48269
@NP	a priori	48327
@NP	transplantation	48371
@NP	LP andOBOECs	48430
@NP	28 d	48472
@NP	lesion	48483
@NP	more GFP LP OECs	48505
@NP	the lesion site	48541
@NP	GFP OB OECs	48566
@NP	the caudal injection point and lesion site -LRB- Fig. 2 -RRB-	48600
@NP	the caudal injection point and lesion site	48600
@NP	Fig. 2	48644
@NP	This distribution	48653
@NP	increased death	48693
@NP	OB OECs at the lesion site or a greater loss of LP OECs at injection sites	48712
@NP	OB OECs at the lesion site	48712
@NP	OB OECs	48712
@NP	the lesion site	48723
@NP	a greater loss of LP OECs at injection sites	48742
@NP	a greater loss	48742
@NP	LP OECs at injection sites	48760
@NP	LP OECs	48760
@NP	injection sites	48771
@NP	The resemblance	48788
@NP	cell distribution of 28 d R/C OBand 7 d R/C LP rats	48807
@NP	cell distribution	48807
@NP	28 d R/C OBand 7 d R/C LP rats	48828
@NP	28 d R/C OBand	48828
@NP	7 d R/C LP rats	48843
@NP	the increased survival ofOB OECs at 28 d	48873
@NP	the increased survival ofOB OECs	48873
@NP	28 d	48909
@NP	the difference in cell distribution	48929
@NP	the difference	48929
@NP	cell distribution	48947
@NP	a result	48978
@NP	intrinsic LP/OB OEC migration differences	48990
@NP	those we assayed in vitro	49046
@NP	those	49046
@NP	we	49052
@NP	Fig. 2	49073
@NP	The ability of OECs to differentially migrate into a lesion site	49082
@NP	The ability	49082
@NP	OECs to differentially migrate into a lesion site	49097
@NP	a lesion site	49133
@NP	important consequences in SCI , because ,	49158
@NP	important consequences	49158
@NP	SCI , because ,	49184
@NP	SCI	49184
@NP	because	49189
@NP	a dorsolateral funiculus lesion	49201
@NP	a cavity forms at 24 h after injury when untreated	49234
@NP	a cavity forms	49234
@NP	24 h	49252
@NP	injury	49263
@NP	Ramer	49286
@NP	et al. , 2004b	49292
@NP	et al.	49292
@NP	2004b	49300
@NP	The greater percentage	49308
@NP	cavity in rats that received rostrocaudal OB OEC transplants	49334
@NP	cavity	49334
@NP	rats that received rostrocaudal OB OEC transplants	49344
@NP	rats	49344
@NP	rostrocaudal OB OEC transplants	49363
@NP	the result of a retarded migration of OB OECs -LRB- Fig. 3 -RRB-	49416
@NP	the result	49416
@NP	a retarded migration of OB OECs -LRB- Fig. 3 -RRB-	49430
@NP	a retarded migration	49430
@NP	OB OECs -LRB- Fig. 3 -RRB-	49454
@NP	OB OECs	49454
@NP	Fig. 3	49463
@NP	The long-term presence of OECs at the lesion site	49472
@NP	The long-term presence	49472
@NP	OECs at the lesion site	49498
@NP	OECs	49498
@NP	the lesion site	49506
@NP	a major determinant of reduced cavity size	49536
@NP	a major determinant	49536
@NP	reduced cavity size	49559
@NP	rostrocaudal LP OEC transplantation	49588
@NP	cavity formation	49646
@NP	direct transplantation -LRB- in which fewer LP OECs survive -RRB-	49677
@NP	direct transplantation	49677
@NP	fewer LP OECs	49710
@NP	Fig. 3	49734
@NP	The decreased lesion site area in rostrocaudally transplanted rats	49743
@NP	The decreased lesion site area	49743
@NP	rostrocaudally transplanted rats	49777
@NP	further	49814
@NP	differences in astrocytic reactions	49835
@NP	differences	49835
@NP	astrocytic reactions	49850
@NP	rostrocaudal versus direct transplantation	49877
@NP	rostrocaudal	49877
@NP	direct transplantation	49897
@NP	Increased GFAP reactivity	49921
@NP	the lesion site	49954
@NP	rats with direct versus rostrocaudal transplants of both OEC types	49973
@NP	rats	49973
@NP	direct versus rostrocaudal transplants of both OEC types	49983
@NP	direct	49983
@NP	rostrocaudal transplants of both OEC types	49997
@NP	rostrocaudal transplants	49997
@NP	both OEC types	50025
@NP	LP and OB OECs	50054
@NP	similar interactions with astrocytes -LRB- Fig. 3 -RRB-	50078
@NP	similar interactions	50078
@NP	astrocytes -LRB- Fig. 3 -RRB-	50104
@NP	astrocytes	50104
@NP	Fig. 3	50116
@NP	the increased GFAP immunoreactivity	50134
@NP	rats that received transplants directly into the lesion site	50173
@NP	rats	50173
@NP	transplants	50192
@NP	the lesion site	50218
@NP	the acute presence of OECs within the lesion	50248
@NP	the acute presence	50248
@NP	OECs within the lesion	50270
@NP	OECs	50270
@NP	the lesion	50282
@NP	astrocyte division	50309
@NP	astrocytic hypertrophy -LRB- Fig. 3 -RRB-	50347
@NP	astrocytic hypertrophy	50347
@NP	Fig. 3	50371
@NP	Differences in astrogliosis	50380
@NP	Differences	50380
@NP	astrogliosis	50395
@NP	unfavorable interactions	50429
@NP	OECs and astrocytes	50462
@NP	-LRB- 2 -RRB- an increased local immune response after direct transplantation	50483
@NP	an	50487
@NP	increased local immune response	50490
@NP	direct transplantation	50528
@NP	a favorable interaction	50559
@NP	OECs and astrocytes that requires long-term survival of OECs	50591
@NP	OECs and astrocytes	50591
@NP	long-term survival of OECs	50625
@NP	long-term survival	50625
@NP	OECs	50647
@NP	Increased astrogliosis	50653
@NP	unfavorable OEC -- astrocyte interactions	50698
@NP	unfavorable OEC	50698
@NP	astrocyte interactions	50714
@NP	astrocyte size , shape , and reactivity	50746
@NP	astrocyte size	50746
@NP	shape	50762
@NP	reactivity	50773
@NP	contact	50812
@NP	OB OECs -LRB- Lakatos et al. , 2000 , 2003 -RRB-	50825
@NP	OB OECs	50825
@NP	Lakatos	50834
@NP	et al. , 2000 , 2003	50842
@NP	et al.	50842
@NP	2000	50850
@NP	2003	50856
@NP	addition	50866
@NP	similar numbers of autofluorescent immune infiltrates	50876
@NP	similar numbers	50876
@NP	autofluorescent immune infiltrates	50895
@NP	the lesion site of rostrocaudally	50951
@NP	the lesion site	50951
@NP	transplanted animals -LRB- of the same cell type -RRB-	50998
@NP	transplanted animals	50998
@NP	the same cell type	51023
@NP	the immune response	51057
@NP	astrogliosis in directly transplanted animals	51134
@NP	astrogliosis	51134
@NP	directly transplanted animals	51150
@NP	the decrease in GFAP intensity in rostrocaudally transplanted rats	51192
@NP	the decrease	51192
@NP	GFAP intensity in rostrocaudally transplanted rats	51208
@NP	GFAP intensity	51208
@NP	rostrocaudally transplanted rats	51226
@NP	a favorable but necessarily prolonged interaction between OECs and astrocytes	51282
@NP	a favorable but necessarily prolonged interaction	51282
@NP	OECs and astrocytes	51340
@NP	this delivery approach	51369
@NP	OEC survival	51406
@NP	The association of OECs and astrocytes	51420
@NP	The association	51420
@NP	OECs and astrocytes	51439
@NP	astrogliosis	51483
@NP	a more permissive environment , allowing SC infiltration and axonal extension	51507
@NP	a more permissive environment	51507
@NP	SC infiltration and axonal extension	51547
@NP	SC infiltration	51547
@NP	axonal extension	51567
@NP	SC transplantation	51585
@NP	behavioral recovery	51617
@NP	SCI -LRB- Pearse et al. , 2004 ; Fouad et al. , 2005 -RRB-	51642
@NP	SCI	51642
@NP	Pearse	51647
@NP	et al. , 2004 ; Fouad et al. , 2005	51654
@NP	et al.	51654
@NP	2004 ; Fouad et al.	51662
@NP	2004	51662
@NP	Fouad et al.	51668
@NP	Fouad	51668
@NP	et al.	51674
@NP	2005	51682
@NP	their infiltration after OEC transplantation	51700
@NP	their infiltration	51700
@NP	OEC transplantation	51725
@NP	regeneration	51779
@NP	OEC type	51806
@NP	functional assessments performed after OB OEC transplantation	51825
@NP	functional assessments	51825
@NP	OB OEC transplantation	51864
@NP	positive outcome measures	51913
@NP	Ramon-Cueto	51940
@NP	et al. , 2000 ; Keyvan-Fouladi et al. , 2003 ; Garcia-Alias et al. , 2004	51952
@NP	et al. , 2000	51952
@NP	et al.	51952
@NP	2000	51960
@NP	Keyvan-Fouladi et al. , 2003	51966
@NP	Keyvan-Fouladi	51966
@NP	et al. , 2003	51981
@NP	et al.	51981
@NP	2003	51989
@NP	Garcia-Alias et al. , 2004	51995
@NP	Garcia-Alias	51995
@NP	et al. , 2004	52008
@NP	et al.	52008
@NP	2004	52016
@NP	the assumption that LP OECs would be similarly beneficial	52028
@NP	the assumption	52028
@NP	LP OECs	52048
@NP	The biological differences	52087
@NP	LP and OB OECs in vitro -LRB- Fig. 2 -RRB-	52131
@NP	LP and OB OECs	52131
@NP	vitro	52149
@NP	Fig. 2	52156
@NP	direct and rostrocaudal transplantation -LRB- Figs. 2 -- 4 -RRB-	52174
@NP	direct and rostrocaudal transplantation	52174
@NP	Figs. 2 -- 4	52215
@NP	Figs. 2	52215
@NP	4	52223
@NP	there	52239
@NP	differences in how OEC type and transplantation approach affect axonal sprouting	52252
@NP	differences	52252
@NP	OEC type and transplantation approach	52271
@NP	OEC type	52271
@NP	transplantation approach	52284
@NP	Sprouting of NF + axons within the lesion site	52334
@NP	Sprouting	52334
@NP	NF + axons within the lesion site	52347
@NP	NF + axons	52347
@NP	the lesion site	52364
@NP	greatest	52384
@NP	rats	52396
@NP	rostrocaudal LP OEC transplants	52415
@NP	little axon density decrease	52453
@NP	the lesion site	52489
@NP	Fig. 5	52506
@NP	contrast	52518
@NP	direct transplantation of LP OECs	52537
@NP	direct transplantation	52537
@NP	LP OECs	52563
@NP	axons	52596
@NP	the lesion boundaries	52609
@NP	fewer axons	52632
@NP	the lesion/host interface	52667
@NP	This effect	52694
@NP	a result	52715
@NP	both trophic/tropic actions of OECs and changes	52727
@NP	trophic/tropic actions of OECs	52732
@NP	trophic/tropic actions	52732
@NP	OECs	52758
@NP	changes	52767
@NP	the permissiveness of the glial scar/lesion site	52778
@NP	the permissiveness	52778
@NP	the glial scar/lesion site	52800
@NP	rostrocaudal transplantation	52836
@NP	GFAP reactivity and cavity formation -LRB- Fig. 3 -RRB-	52880
@NP	GFAP reactivity and cavity formation	52880
@NP	Fig. 3	52918
@NP	permissiveness	52938
@NP	tropic actions	52966
@NP	rostrocaudal	53001
@NP	direct , LP OEC transplantation	53032
@NP	direct	53032
@NP	LP OEC transplantation	53040
@NP	only the location of the cell transplant	53076
@NP	only the location	53076
@NP	the cell transplant	53097
@NP	differences in NF + growth	53138
@NP	differences	53138
@NP	NF + growth	53153
@NP	NF	53153
@NP	growth	53157
@NP	evidence from LP OECs	53180
@NP	evidence	53180
@NP	LP OECs	53194
@NP	one	53203
@NP	greater	53224
@NP	NF + axons within the lesion	53232
@NP	NF + axons	53232
@NP	the lesion	53249
@NP	site in rats transplanted rostrocaudally than directly with OB OECs	53260
@NP	site	53260
@NP	rats transplanted rostrocaudally than directly with OB OECs	53268
@NP	rats	53268
@NP	OB OECs	53320
@NP	-LRB- 2 -RRB- the same amount of NF	53332
@NP	the same amount	53336
@NP	NF	53355
@NP	growth within the lesion site in rostrocaudal LP - and OB-treated rats	53359
@NP	growth	53359
@NP	the lesion site in rostrocaudal LP - and OB-treated rats	53373
@NP	the lesion site	53373
@NP	rostrocaudal LP - and OB-treated rats	53392
@NP	A comparison of only rostrocaudally transplanted LP and OB OEC rats	53430
@NP	A comparison	53430
@NP	only rostrocaudally transplanted LP and OB OEC rats	53446
@NP	only rostrocaudally transplanted LP	53446
@NP	OB OEC rats	53486
@NP	significantly greater NF + axons	53509
@NP	NF + axons	53531
@NP	the lesion in LP-treated rats -LRB- Fig. 5 -RRB-	53560
@NP	the lesion	53560
@NP	LP-treated rats -LRB- Fig. 5 -RRB-	53574
@NP	LP-treated rats	53574
@NP	Fig. 5	53591
@NP	This	53600
@NP	LP and OB OECs	53619
@NP	different neurotrophic factors	53648
@NP	them	53694
@NP	different levels	53702
@NP	The significant increase in autotomy in LP OEC versus OB OEC transplant groups	53720
@NP	The significant increase	53720
@NP	autotomy in LP OEC versus OB OEC transplant groups	53748
@NP	autotomy	53748
@NP	LP OEC versus OB OEC transplant groups	53760
@NP	LP OEC	53760
@NP	OB OEC transplant groups	53774
@NP	potential functional differences between these two cell types	53819
@NP	potential functional differences	53819
@NP	these two cell types	53860
@NP	the mechanisms of autotomy	53891
@NP	the mechanisms	53891
@NP	autotomy	53909
@NP	autotomy	53938
@NP	denervation or situations	53963
@NP	sensory modalities	53998
@NP	our model	54040
@NP	it	54063
@NP	OEC transplantation	54079
@NP	the sensory system	54119
@NP	differential growth of different axonal populations	54154
@NP	differential growth	54154
@NP	different axonal populations	54177
@NP	local circuitry	54236
@NP	These possibilities	54253
@NP	a higher degree of plasticity/remodeling	54284
@NP	a higher degree	54284
@NP	plasticity/remodeling	54303
@NP	LP versus OB OECs , which could result in undesired effects	54343
@NP	LP versus OB OECs	54343
@NP	undesired effects	54384
@NP	comparison	54406
@NP	recent work with transplanted embryonic stem cells into SCI	54418
@NP	recent work	54418
@NP	transplanted embryonic stem cells into SCI	54435
@NP	transplanted embryonic stem cells	54435
@NP	SCI	54474
@NP	the development of allodynia	54491
@NP	the development	54491
@NP	allodynia	54510
@NP	addition	54523
@NP	increased motor function	54535
@NP	a feature	54561
@NP	mostOECtransplantation studies -LRB- Hofstetter et al. , 2005 -RRB-	54585
@NP	mostOECtransplantation studies	54585
@NP	Hofstetter	54617
@NP	et al. , 2005	54628
@NP	et al.	54628
@NP	2005	54636
@NP	The differential sprouting of some axonal populations	54643
@NP	The differential	54643
@NP	some axonal populations	54673
@NP	LP and OB OECs	54718
@NP	different neurotrophic factors	54741
@NP	recovery -LRB- Fig. 8 -RRB-	54810
@NP	recovery	54810
@NP	Fig. 8	54820
@NP	subP + axons	54829
@NP	subP	54829
@NP	axons	54835
@NP	OB	54872
@NP	LP-treated rats -LRB- Fig. 8 -RRB-	54881
@NP	LP-treated rats	54881
@NP	Fig. 8	54898
@NP	the most robust difference in sprouting	54916
@NP	the most robust difference	54916
@NP	the growth	54960
@NP	TH + neurons	54974
@NP	growth	54993
@NP	LP OEC transplantation -LRB- Fig. 8 -RRB-	55023
@NP	LP OEC transplantation	55023
@NP	Fig. 8	55047
@NP	Differences in the abilities of LP and OB OECs to promote axon elongation	55056
@NP	Differences	55056
@NP	the abilities of LP and OB OECs to promote axon elongation	55071
@NP	the abilities	55071
@NP	LP and OB OECs	55088
@NP	axon elongation	55114
@NP	accord with their roles in the olfactory neuraxis	55137
@NP	accord	55137
@NP	their roles in the olfactory neuraxis	55149
@NP	their roles	55149
@NP	the olfactory neuraxis	55164
@NP	we	55679
@NP	the first data	55690
@NP	LP and OB OEC transplantation in a single SCI model	55724
@NP	LP and OB OEC transplantation	55724
@NP	a single SCI model	55757
@NP	there	55790
@NP	fundamental differences	55800
@NP	intrinsic OEC properties	55827
@NP	they	55876
@NP	lesioned spinal cord	55903
@NP	These differences	55925
@NP	the ability	55957
@NP	a permissive regeneration-promoting environment	55991
@NP	the lesion site	56042
@NP	-LRB- 2 -RRB- differential outgrowth-promoting characteristics of LP and OB OECs	56062
@NP	differential outgrowth-promoting characteristics	56066
@NP	LP and OB OECs	56118
@NP	the maximal benefit to most regeneration parameters	56143
@NP	the maximal benefit	56143
@NP	most regeneration parameters	56166
@NP	rostrocaudal LP OEC transplantation	56213
@NP	this	56250
@NP	autotomy	56279
@NP	This	56289
@NP	the vigorous sprouting associated with rostrocaudal LP OEC transplantation	56308
@NP	the vigorous	56308
@NP	rostrocaudal LP OEC transplantation	56347
@NP	appropriate connections	56410
@NP	nearby uninjured tracts	56470
@NP	rostrocaudal LP OEC transplantation	56528
@NP	the greatest opportunity	56573
@NP	regeneration	56609
@NP	local circuitry	56635
@NP	SCI	56657
@NP	LP OECs , combined with directed axon guidance stimulation ,	56678
@NP	LP OECs	56678
@NP	directed axon guidance stimulation	56701
@NP	additional development	56747
@NP	a means to restore motor and sensory function after spinal cord lesion	56773
@NP	motor and sensory function	56792
@NP	spinal cord lesion	56825
@VP	Promote Differential Axon Sprouting in the Lesioned Spinal Cord Miranda W.	104
@VP	derived from a common embryonic precursor	703
@VP	reside in different nervous system compartments postnatally	767
@VP	to promote regeneration and efficacy after transplantation	846
@VP	promote regeneration and efficacy after transplantation	849
@VP	may differ depending on both their source and mode of transplantation	905
@VP	differ depending on both their source and mode of transplantation	909
@VP	purified green fluorescent protein-expressing LP and OB OECs	990
@VP	assayed their biological differences in vitro	1052
@VP	transplanted them acutely either directly into	1103
@VP	rostral and caudal to a dorsolateral funiculus crush	1153
@VP	exhibit multiple morphological and antigenic similarities in vitro	1222
@VP	attenuate lesion and cavity formation	1328
@VP	sprouting	1441
@VP	to migrate within the spinal cord	1577
@VP	migrate within the spinal cord	1580
@VP	reduce cavity formation and lesion size	1612
@VP	was also significantly enhanced by LP OEC , over OB OEC , transplantation	1773
@VP	significantly enhanced by LP OEC , over OB OEC , transplantation	1782
@VP	vary depending on direct versus rostrocaudal transplantation	2105
@VP	can occur even after central axotomy -LRB- Zigova et al. , 1992 -RRB-	2364
@VP	occur even after central axotomy -LRB- Zigova et al. , 1992 -RRB-	2368
@VP	exit the olfactory epithelium	3587
@VP	extend toward theOB -LRB- Williams et al. , 2004 -RRB-	3621
@VP	enter the nerve fiber layer of the OB	3676
@VP	associate with astrocytes -LRB- Au et al. , 2002 -RRB-	3759
@VP	in morphology and function in vitro	3855
@VP	suggest they may exhibit different properties when transplanted after SCI	4071
@VP	may exhibit different properties when transplanted after SCI	4084
@VP	exhibit different properties when transplanted after SCI	4088
@VP	transplanted after SCI	4122
@VP	could influence integration and long-term cell survival of transplanted cells	4449
@VP	influence integration and long-term cell survival of transplanted cells	4455
@VP	expressing OECs	4845
@VP	establishing their expansion and phenotype in vitro	4940
@VP	transplanted them directly or rostrocaudally into a dorsolateral funiculus crush	5004
@VP	examined	5098
@VP	to promote directional angiogenesis	5158
@VP	promote directional angiogenesis	5161
@VP	sprouting differences between LP and OB OECtreated animals	5297
@VP	resulting from transplantation of these two cell populations	5397
@VP	expressed under the betta-actin promoter	5818
@VP	driven by the cytomegalovirus enhancer -LRB- Au and Roskams , 2003 -RRB-	5863
@VP	dissected from 8 -- 10 pups	5992
@VP	mechanically dissociated	6018
@VP	using anti-Thy1.1-mediated complement lysis	6492
@VP	to remove contaminating fibroblasts -LRB- Au and Roskams , 2003 -RRB-	6561
@VP	remove contaminating fibroblasts -LRB- Au and Roskams , 2003 -RRB-	6564
@VP	contaminating fibroblasts -LRB- Au and Roskams , 2003 -RRB-	6571
@VP	replated in DMEM/F -12 , 10 % FBS , and 100 U/ml P/S	6632
@VP	were again subjected to Thy1.1-mediated complement lysis	6736
@VP	subjected to Thy1.1-mediated complement lysis	6747
@VP	were plated at a density of 5600 cells/cm 2 into T75 flasks for transplantation	6802
@VP	plated at a density of 5600 cells/cm 2 into T75 flasks for transplantation	6807
@VP	varied from 14 to 16 d in vitro -LRB- DIV -RRB-	6927
@VP	sagittally bisecting the head	7062
@VP	removing the meningeal covering of the olfactory bulb	7093
@VP	using a scalpel to partition the rostralmost quarter of the olfactory bulb	7148
@VP	extracting the portion of the nerve fiber layer next to the cribriform plate	7228
@VP	dissociated and cultured as described by Ramon-Cueto et al. -LRB- 1998 -RRB-	7330
@VP	described by Ramon-Cueto et al. -LRB- 1998 -RRB-	7358
@VP	was followed by dissociation by multiple passes through fire-polished pipettes	7452
@VP	followed by dissociation by multiple passes through fire-polished pipettes	7456
@VP	had grown to -80 % confluency	7807
@VP	grown to -80 % confluency	7811
@VP	were purified by immunopanning	7845
@VP	purified by immunopanning	7850
@VP	room temperature , p75 ; Chemicon , Temecula ,	8188
@VP	temperature , p75 ; Chemicon , Temecula ,	8193
@VP	, p75 ; Chemicon , Temecula ,	8204
@VP	were incubated for 30 min at 37 °C	8242
@VP	incubated for 30 min at 37 °C	8247
@VP	were then washed away , and bound cells were detached using a cell lifter	8291
@VP	were then washed away	8291
@VP	washed away	8301
@VP	bound cells were detached using a cell lifter	8318
@VP	were detached using a cell lifter	8330
@VP	detached using a cell lifter	8335
@VP	using a cell lifter	8344
@VP	being plated at a density of 6500 cells/cm 2 into T75 flasks for transplantation	8560
@VP	plated at a density of 6500 cells/cm 2 into T75 flasks for transplantation	8566
@VP	was between 14 and 16 DIV	8686
@VP	using 0.25 % trypsin/1 % EDTA	8831
@VP	ensuring that every rat received freshly harvested cells	9030
@VP	received freshly harvested cells	9054
@VP	To assess cell purity	9145
@VP	assess cell purity	9148
@VP	express typical morphology and phenotype before transplantation	9192
@VP	plated onto glass slides after the second subculture	9275
@VP	fixed in 4 % paraformaldehyde -LRB- PFA -RRB- after 2 DIV	9332
@VP	incubated overnight at 4 °C	9454
@VP	coverslipped in Vectashield mounting media	9968
@VP	to determine the optimal time and antibody concentrations for immunopanning	10054
@VP	determine the optimal time and antibody concentrations for immunopanning	10057
@VP	described above	10219
@VP	described above	10330
@VP	counted , as well as p75 + cells to assess for the enrichment of p75 + cells	10364
@VP	to assess for the enrichment of p75 + cells	10395
@VP	assess for the enrichment of p75 + cells	10398
@VP	optimizing cell purification procedures	10445
@VP	described above for LP OECs	10608
@VP	cultured for the same DIV	10678
@VP	harvested at passage 2	10709
@VP	contained 2.5 % FBS in DMEM/F -12	10942
@VP	migrated for 20 h	10981
@VP	were then swabbed	11041
@VP	then swabbed	11046
@VP	were swabbed for negative controls	11071
@VP	swabbed for negative controls	11076
@VP	was swabbed for positive controls	11124
@VP	swabbed for positive controls	11128
@VP	fixed in 0.1 % glutaraldehyde in 4 % PFA in PBS for 30 min at room temperature	11175
@VP	mounted onto glass slides	11292
@VP	coverslipped with Vectashield -LRB- Vector Laboratories -RRB-	11319
@VP	were collected , encompassing the entire membrane	11386
@VP	collected , encompassing the entire membrane	11391
@VP	encompassing the entire membrane	11402
@VP	were counted	11449
@VP	counted	11454
@VP	divided by the total cells on positive membranes	11588
@VP	were approved by the Animal Care Committee of the University of British Columbia	11825
@VP	approved by the Animal Care Committee of the University of British Columbia	11830
@VP	performed , exposing the left halves of the third and fourth cervical segments	12290
@VP	exposing the left halves of the third and fourth cervical segments	12301
@VP	was then cut with microscissors , exposing the spinal cord	12378
@VP	cut with microscissors , exposing the spinal cord	12387
@VP	exposing the spinal cord	12411
@VP	were then closed for 18 -- 20 s , crushing the dorsolateral funiculus	12629
@VP	closed for 18 -- 20 s , crushing the dorsolateral funiculus	12639
@VP	crushing the dorsolateral funiculus	12659
@VP	severs all rubrospinal axons -LRB- Ramer et al. , 2004 -RRB-	12772
@VP	were designated to cell transplantation and control groups after crush	12876
@VP	designated to cell transplantation and control groups after crush	12881
@VP	drawn into a pulled glass pipette with a diameter of 20µm in a Hamilton syringe	13015
@VP	dividing the cell suspension equally	13235
@VP	received a total of 75,000 -- 90,000 cells	13620
@VP	injected at the same sites at the same rate	13716
@VP	remained in the spinal cord and were not withdrawn with the syringe	13849
@VP	remained in the spinal cord	13849
@VP	were not withdrawn with the syringe	13881
@VP	withdrawn with the syringe	13890
@VP	was slowly pulled back	13947
@VP	pulled back	13958
@VP	were closed with interrupted sutures	13995
@VP	closed with interrupted sutures	14000
@VP	were as follows	14058
@VP	follows	14066
@VP	were as follows	14227
@VP	follows	14235
@VP	killed with a lethal overdose of chloral hydrate -LRB- 100 mg/kg , i.p. -RRB-	14404
@VP	transcardially perfused with PBS	14475
@VP	followed by 4 % PFA	14509
@VP	dissected	14574
@VP	were collected at 14 µm and stored at -20 °C	14827
@VP	were collected at 14 µm	14827
@VP	collected at 14 µm	14832
@VP	stored at -20 °C	14855
@VP	used for most detection	14912
@VP	were as follows	14936
@VP	follows	14944
@VP	raised in goat and conjugated to Alexa 350 , 488	15820
@VP	raised in goat	15820
@VP	conjugated to Alexa 350 , 488	15839
@VP	were applied for 1 h at room temperature	15876
@VP	applied for 1 h at room temperature	15881
@VP	were then coverslipped in Vectashield -LRB- Vector Laboratories -RRB-	15931
@VP	coverslipped in Vectashield -LRB- Vector Laboratories -RRB-	15941
@VP	defined levels , 0.65 , 0.9 , and 1.15 mm ventral in the spinal cord	16533
@VP	calculating the total pixels in this area	16604
@VP	performed on sections at 0.9 mm ventral for all animals in each treatment group	16675
@VP	were first removed by recoloring triplefluorescing items in black	16931
@VP	removed by recoloring triplefluorescing items in black	16942
@VP	recoloring triplefluorescing items in black	16953
@VP	was performed by outlining the GFAP-reactive border	17121
@VP	performed by outlining the GFAP-reactive border	17125
@VP	outlining the GFAP-reactive border	17138
@VP	to normalize staining between animals	17230
@VP	normalize staining between animals	17233
@VP	were counted	17317
@VP	counted	17322
@VP	were quantified as	17494
@VP	quantified as	17499
@VP	described for within lesion measured	17513
@VP	measured	17541
@VP	binning and counting pixels in the three top bins	17554
@VP	used to quantify GFP + items at locations within the lesion site , or 0.5	17628
@VP	to quantify GFP + items at locations within the lesion site , or 0.5	17633
@VP	quantify GFP + items at locations within the lesion site , or 0.5	17636
@VP	1mmrostral and caudal to the lesion site	17704
@VP	fluorescing in all three channels	17752
@VP	were colored black	17786
@VP	colored black	17791
@VP	were counted within selection areas measuring 750,000 pixels	17836
@VP	counted within selection areas measuring 750,000 pixels	17841
@VP	measuring 750,000 pixels	17872
@VP	performed using programs designed on Matlab -LRB- MathWorks , Natick , MA -RRB-	17947
@VP	using programs designed on Matlab -LRB- MathWorks , Natick , MA -RRB-	17957
@VP	designed on Matlab -LRB- MathWorks , Natick , MA -RRB-	17972
@VP	stained with anti-RECA	18046
@VP	were automatically posterized to two levels	18069
@VP	posterized to two levels	18088
@VP	were recursively mapped and counted	18151
@VP	mapped and counted	18168
@VP	was applied	18208
@VP	applied	18212
@VP	were then mapped onto the same x -- y plane as the original image	18252
@VP	mapped onto the same x -- y plane as the original image	18262
@VP	defined by an outline of the GFAP scar	18377
@VP	was assessed	18417
@VP	assessed	18421
@VP	to ascertain a baseline value of directionality	18514
@VP	ascertain a baseline value of directionality	18517
@VP	is reported	18630
@VP	reported	18633
@VP	using Tukey 's tests	18717
@VP	were used to compare across groups	18737
@VP	used to compare across groups	18742
@VP	to compare across groups	18747
@VP	compare across groups	18750
@VP	are presented with error bars representing SEM	18788
@VP	presented with error bars representing SEM	18792
@VP	representing SEM	18818
@VP	exhibit similar antigenic and morphological properties in vitro	18870
@VP	express p75 and S100betta -LRB- C , D -RRB-	18977
@VP	flattened -LRB- arrow -RRB- morphology	19031
@VP	differ in their ability to migrate in vivo and in vitro	19157
@VP	to migrate in vivo and in vitro	19181
@VP	migrate in vivo and in vitro	19184
@VP	transplanted GFP + LP OECs	19240
@VP	denoted by GFAP immunoreaction -LRB- red pseudocolor -RRB-	19356
@VP	transplanted GFP + OB OECs	19418
@VP	surviving GFP + cells	19524
@VP	resembles migrating R/C LP OECs at 7 d -LRB- C -RRB-	19587
@VP	migrating R/C LP OECs at 7 d -LRB- C -RRB-	19597
@VP	reveals significantly more GFP	19751
@VP	using a Boyden chamber migration assay	19881
@VP	migrate 60 % less than LP OECs after 20 h on PLL	19929
@VP	migrating 85 % less than LP OECs -LRB- n = 3 ; p ≤ 0.02 , all groups -RRB-	20046
@VP	are presented as mean ± SEM	20110
@VP	presented as mean ± SEM	20114
@VP	are decreased in LP - versus OB-treated rats	20206
@VP	decreased in LP - versus OB-treated rats	20210
@VP	is increased by direct transplantation	20264
@VP	increased by direct transplantation	20267
@VP	to assess lesion site area -LRB- white line -RRB- and cavity	20553
@VP	assess lesion site area -LRB- white line -RRB- and cavity	20556
@VP	formed in direct OB	20777
@VP	is significantly greater than LP	20797
@VP	as measured by GFAP intensity in a defined area around the lesion site	21180
@VP	normalized to GFAP on the contralateral side	21251
@VP	are presented as mean ± SEM	21694
@VP	presented as mean ± SEM	21698
@VP	promote Schwann cell infiltration	21806
@VP	associating closely	21969
@VP	sprouting into the lesion site	22152
@VP	is highly promoted by rostrocaudal LP OEC transplantation	22183
@VP	promoted by rostrocaudal LP OEC transplantation	22193
@VP	determined by outlining the GFAP-reactive border	22497
@VP	outlining the GFAP-reactive border	22511
@VP	transplanted rats	22881
@VP	are presented as mean ± SEM	23016
@VP	presented as mean ± SEM	23020
@VP	promote directional angiogenesis	23089
@VP	recognized by anti-RECA immunoreaction -LRB- red -RRB-	23140
@VP	constructing best-fit lines to RECA-positive structures	23327
@VP	to determine a contour map of intersection points	23445
@VP	determine a contour map of intersection points	23448
@VP	indicated in the color scale bar	23639
@VP	outlines in G -- K	23748
@VP	indicated by anti-GFAP -LRB- green pseudocolor -RRB-	23769
@VP	to produce a directionality quotient	23918
@VP	produce a directionality quotient	23921
@VP	normalized for tissue area	24016
@VP	are presented in Table 1	24044
@VP	presented in Table 1	24048
@VP	is reduced by OB OEC transplantation but elevated by LP OEC transplantation	24109
@VP	is reduced by OB OEC transplantation	24109
@VP	reduced by OB OEC transplantation	24112
@VP	elevated by LP OEC transplantation	24150
@VP	, Schematic of scoring system for autotomy ; from left to right	24187
@VP	, Schematic of scoring system for autotomy	24187
@VP	left to right	24236
@VP	would be	24258
@VP	be	24264
@VP	assigned as 1 , 2 , and 3 , respectively	24267
@VP	do not differ significantly from control rats	24588
@VP	differ significantly from control rats	24595
@VP	are presented as mean ± SEM	24730
@VP	presented as mean ± SEM	24734
@VP	are differentially responsive to LP and OB OEC transplantation	24805
@VP	shows significantly increased subP in OB OEC animals 1	25025
@VP	sprouting 5-HT-positive axons in LP -LRB- G -RRB- and OB -LRB- H -RRB-	25468
@VP	penetrate caudal to the lesion -LRB- G , H , insets -RRB-	25666
@VP	quantified by immunofluorescence densitometry	25801
@VP	J , inset	25948
@VP	inset	26031
@VP	are white	26082
@VP	are presented as mean ± SEM	26098
@VP	presented as mean ± SEM	26102
@VP	To assess their comparative ability to promote regeneration	26146
@VP	assess their comparative ability to promote regeneration	26149
@VP	to promote regeneration	26182
@VP	promote regeneration	26185
@VP	grown for 14 DIV	26421
@VP	exhibited both flattened and fusiform morphologies -LRB- Fig. 1A , B -RRB-	26565
@VP	exhibited	26565
@VP	flattened and fusiform morphologies -LRB- Fig. 1A , B -RRB-	26580
@VP	demonstrated a broader range of p75 expression than LP OECs	26637
@VP	demonstrated low p75 levels -LRB- Fig. 1B -RRB-	26758
@VP	Purified passage 2 eGFP + LP and OB OECs cultured for 14 DIV	26953
@VP	cultured for 14 DIV	26993
@VP	may be predicted based on their home environments	27187
@VP	be predicted based on their home environments	27191
@VP	predicted based on their home environments	27194
@VP	to migrate within the CNS and preferential interactions with endogenous glia	27315
@VP	migrate within the CNS and preferential interactions with endogenous glia	27318
@VP	were already found at the lesion site	27669
@VP	found at the lesion site	27682
@VP	arranged in a stream from the rostral injection point to lesion center	27746
@VP	retained 42 ± 10.6 % of total LP-OECs and 28 ± 6.2 % OB OECs transplanted	27894
@VP	transplanted	27949
@VP	differed significantly between OEC types -LRB- n = 3 , 4 ; p ≤ 0.05 -RRB-	28465
@VP	quantifying GFP + OEC distribution	28662
@VP	surviving GFP + OB OECs in rostrocaudally transplanted rats	28704
@VP	surviving GFP + cells found within the lesion site	29066
@VP	found within the lesion site	29087
@VP	represented intrinsic differences in migratory ability of LP and OB OECs	29174
@VP	was used	29271
@VP	used	29275
@VP	were allowed to passively migrate through the membrane	29423
@VP	allowed to passively migrate through the membrane	29428
@VP	to passively migrate through the membrane	29436
@VP	passively migrate through the membrane	29439
@VP	were assayed	29533
@VP	assayed	29538
@VP	migrated thanOBOECs on PLL -LRB- n = 3 ; p ≤ 0.02 -RRB-	29598
@VP	migrated -LRB- Fig. 2E -RRB-	29731
@VP	suggest that , in vivo and in vitro , LP OECs migrate more readily than OB OECs	29762
@VP	migrate more readily than OB OECs	29806
@VP	decreased by LP versus OB OEC transplantation Differences in migratory ability	29883
@VP	are able to minimize lesion and cavity formation during the acute phase of SCI	30004
@VP	to minimize lesion and cavity formation during the acute phase of SCI	30013
@VP	minimize lesion and cavity formation during the acute phase of SCI	30016
@VP	To test whether differential migration correlated with lesion size	30084
@VP	test whether differential migration correlated with lesion size	30087
@VP	correlated with lesion size	30123
@VP	used the GFAPreactive border as a marker of the perimeter of the lesion area	30155
@VP	exhibited an easily defined lesion area containing some evidence of a cavity	30350
@VP	containing some evidence of a cavity	30390
@VP	received directOBOEC transplants -LRB- Fig. 3A -RRB-	30447
@VP	received the same cells rostrocaudally	30601
@VP	transplanted either directly	30685
@VP	rostrocaudally	30727
@VP	received direct	30792
@VP	received LP OECs transplanted rostrocaudally	31047
@VP	transplanted rostrocaudally	31064
@VP	a trend not observed after rostrocaudal OB OEC transplantation	31208
@VP	occupying 93 ± 3.3 %	31565
@VP	are major obstacles to axonal regeneration -LRB- Schwab , 2002 -RRB-	31721
@VP	produced by reactive astrocytes	31812
@VP	altered the lesion site and cavity area	32061
@VP	might occur differentially between treatment groups	32147
@VP	occur differentially between treatment groups	32153
@VP	surrounding and including the lesion site	32326
@VP	defined area of GFAP immunoreactivity contralateral to the lesion site	32403
@VP	to direct injection of media -LRB- Fig. 3A , C , H -RRB-	32662
@VP	direct injection of media -LRB- Fig. 3A , C , H -RRB-	32665
@VP	observed in rostrocaudal versus direct transplanted rats	33273
@VP	not shown	33552
@VP	reported previously	33573
@VP	could also significantly affect regeneration outcomes	33750
@VP	significantly affect regeneration outcomes	33761
@VP	are highly permissive for regeneration	33825
@VP	may stimulate regeneration	34052
@VP	stimulate regeneration	34056
@VP	do not know whether OB OECs also promote SC infiltration in this lesion paradigm	34202
@VP	know whether OB OECs also promote SC infiltration in this lesion paradigm	34209
@VP	promote SC infiltration in this lesion paradigm	34235
@VP	measured from the GFAP lesion boundary	34801
@VP	were found maximally at 350 µm	34911
@VP	found maximally at 350 µm	34916
@VP	was rarely seen in control animals -LRB- Fig. 4E -RRB-	34990
@VP	rarely seen in control animals -LRB- Fig. 4E -RRB-	34994
@VP	did not penetrate beyond 80 µm of the lesion boundary	35039
@VP	penetrate beyond 80 µm of the lesion boundary	35047
@VP	infiltrated after OEC transplantation	35103
@VP	to recruit , activate , or cooperate with endogenous Schwann cells	35382
@VP	recruit , activate , or cooperate with endogenous Schwann cells	35385
@VP	recruit	35385
@VP	activate	35394
@VP	cooperate with endogenous Schwann cells	35407
@VP	sprouting into the lesion site	35455
@VP	to promote repair	35647
@VP	promote repair	35650
@VP	secreted factors released into an SCI lesion area	35927
@VP	released into an SCI lesion area	35944
@VP	may uniformly promote repair throughout the lesion site	35977
@VP	promote repair throughout the lesion site	35991
@VP	could directly change repair and regeneration parameters	36069
@VP	change repair and regeneration parameters	36084
@VP	expressing NF	36147
@VP	were transplanted	36273
@VP	transplanted	36278
@VP	was direct or rostrocaudal	36316
@VP	to differ between treatment groups	36506
@VP	differ between treatment groups	36509
@VP	received direct transplants of LP and OB OECs	36594
@VP	were visible within the lesion site in both direct transplant groups	36789
@VP	received rostrocaudal LPOEC transplants	37001
@VP	received LP or OB OECs transplanted directly into the lesion	37284
@VP	transplanted directly into the lesion	37307
@VP	received rostrocaudal OB OEC transplants	37356
@VP	outlining the GFAP-reactive border	37644
@VP	counting NF + pixels within this area -LRB- Fig. 5E -RRB-	37683
@VP	received OB OECs directly at the lesion site	37926
@VP	differentially influenced the pattern of growth of sprouting axons	38165
@VP	sprouting axons	38216
@VP	also affected their ability to penetrate the lesion site	38236
@VP	to penetrate the lesion site	38264
@VP	penetrate the lesion site	38267
@VP	treated by rostrocaudal LP OEC transplantation -LRB- Fig. 5A -RRB-	38414
@VP	appeared directed toward the lesion site	38472
@VP	directed toward the lesion site	38481
@VP	occurs after LP OEC transplantation	38576
@VP	extend along blood vessel laminas -LRB- Ramer et al. , 2004b -RRB-	38633
@VP	has also been demonstrated after contusive injury -LRB- Loy et al. , 2002 -RRB-	38754
@VP	been demonstrated after contusive injury -LRB- Loy et al. , 2002 -RRB-	38763
@VP	demonstrated after contusive injury -LRB- Loy et al. , 2002 -RRB-	38768
@VP	may be related to the direction of blood vessel growth	38884
@VP	be related to the direction of blood vessel growth	38888
@VP	related to the direction of blood vessel growth	38891
@VP	becoming entangled at the lesion site	39112
@VP	To assess the extent and directionality of blood vessel growth	39151
@VP	assess the extent and directionality of blood vessel growth	39154
@VP	To analyze directionality	39327
@VP	analyze directionality	39330
@VP	assigned a threshold intensity -LRB- applied within and across groups -RRB-	39422
@VP	applied within and across groups	39454
@VP	counted	39489
@VP	to determine their direction of growth -LRB- Fig. 6F -RRB-	39593
@VP	determine their direction of growth -LRB- Fig. 6F -RRB-	39596
@VP	randomly placed throughout the same spinal cord	39906
@VP	normalized for lesion area and for number of blood vessels	40052
@VP	indicate directionality of blood vessels toward the lesion site	40147
@VP	were directly transplanted with OB OECs	40572
@VP	transplanted with OB OECs	40586
@VP	may favor directed axon growth within the CNS	40910
@VP	favor directed axon growth within the CNS	40914
@VP	is reduced by OB OEC	40966
@VP	reduced by OB OEC	40969
@VP	resulted in the enhanced growth of NF axons within the lesion site	41066
@VP	licking , grooming , and biting of the anesthetic limb	41629
@VP	licking	41629
@VP	grooming	41638
@VP	biting of the anesthetic limb	41652
@VP	were awarded for the attack of each digit	41857
@VP	awarded for the attack of each digit	41862
@VP	was scored as well as the left hindpaw , which served as an internal control	42112
@VP	scored as well as the left hindpaw , which served as an internal control	42116
@VP	served as an internal control	42158
@VP	received direct transplants of LP OECs	42199
@VP	was less in OB-treated rats	42784
@VP	Sprouting of TH - , subP -	42813
@VP	Sprouting of TH	42813
@VP	may differentially stimulate axonal sprouting that could contribute to autotomy	42953
@VP	stimulate axonal sprouting that could contribute to autotomy	42972
@VP	sprouting that could contribute to autotomy	42989
@VP	could contribute to autotomy	43004
@VP	contribute to autotomy	43010
@VP	to autotomy	43021
@VP	autotomy	43024
@VP	expressing CGRP + or subP + -LRB- Ramer et al. , 2004b -RRB-	43289
@VP	expressing CGRP + or subP +	43289
@VP	using the GFAP + border to identify the boundaries of the lesion site	43441
@VP	to identify the boundaries of the lesion site	43464
@VP	identify the boundaries of the lesion site	43467
@VP	defined areas 0.5 and 1 mm rostral and caudal to the lesion	43628
@VP	tested	43817
@VP	were absent from the lesion site	43824
@VP	received LP OECs -LRB- Fig. 8A -RRB- and OB OECs -LRB- Fig. 8B -RRB-	44033
@VP	were found within the lesion site but were increased caudal to the lesion site	44103
@VP	were found within the lesion site	44103
@VP	found within the lesion site	44108
@VP	were increased caudal to the lesion site	44141
@VP	increased caudal to the lesion site	44146
@VP	are presented collectively	44389
@VP	presented collectively	44393
@VP	inset	44505
@VP	inset	44587
@VP	transplanted rats	44594
@VP	promoting the sprouting of subP-positive axons after injury	44841
@VP	are also responsive to LP OEC transplantation -LRB- Ramer et al. , 2004b -RRB-	44961
@VP	sprouting	45040
@VP	could impact pain sensation after SCI -LRB- Jang et al. , 2004 -RRB-	45050
@VP	impact pain sensation after SCI -LRB- Jang et al. , 2004 -RRB-	45056
@VP	demonstrated	45366
@VP	increased sprouting at the rostral lesion border -LRB- Fig. 8D , inset , F -RRB-	45379
@VP	sprouting at the rostral lesion border -LRB- Fig. 8D , inset , F -RRB-	45389
@VP	did	45467
@VP	was visible at 24 h after lesion	45624
@VP	sprouting	45701
@VP	were observed between direct and rostrocaudally transplanted rats	45711
@VP	observed between direct and rostrocaudally transplanted rats	45716
@VP	appeared similar in both LP - and OB-treated rats -LRB- Fig. 8G , H -RRB-	45822
@VP	was extensive compared with CGRP + and subP	45887
@VP	sprouting	45931
@VP	received LP OECs compared with OB OECs -LRB- Fig. 8J -- L -RRB-	46285
@VP	inset	46468
@VP	inset	46515
@VP	promote growth of these axon subtypes	46666
@VP	to repair the injured CNS -LRB- Lakatos and Franklin , 2002 -RRB-	46788
@VP	repair the injured CNS -LRB- Lakatos and Franklin , 2002 -RRB-	46791
@VP	containing LP OECs	47060
@VP	are functionally equivalent	47173
@VP	compared the effect of transplanting OB and LP OECs into lesioned spinal cord	47313
@VP	transplanting OB and LP OECs into lesioned spinal cord	47336
@VP	determined that they produce significantly different regeneration outcomes	47395
@VP	produce significantly different regeneration outcomes	47416
@VP	sprouting of NF	47552
@VP	also stimulate autotomy	47586
@VP	increases lesion site area and cavity formation	47647
@VP	promotes sprouting of subP + axons	47696
@VP	sprouting of subP + axons	47705
@VP	promotes the greatest directional angiogenesis	47735
@VP	have different abilities to migrate	47875
@VP	to migrate	47900
@VP	migrate	47903
@VP	affects astrogliosis , NF + sprouting , and cavity formation	47955
@VP	suggest that both OEC types are very similar	48093
@VP	are very similar	48121
@VP	should not be considered functional equals a priori	48284
@VP	be considered functional equals a priori	48295
@VP	considered functional equals a priori	48298
@VP	equals a priori	48320
@VP	could behave differently after transplantation	48340
@VP	behave differently after transplantation	48346
@VP	transplanted rostrocaudally	48401
@VP	were distributed differently 28 d after lesion	48443
@VP	distributed differently 28 d after lesion	48448
@VP	coupled with the increased survival ofOB OECs at 28 d	48860
@VP	resemble those we assayed in vitro	49037
@VP	assayed in vitro	49055
@VP	to differentially migrate into a lesion site	49102
@VP	differentially migrate into a lesion site	49105
@VP	received rostrocaudal OB OEC transplants	49354
@VP	be the result of a retarded migration of OB OECs -LRB- Fig. 3 -RRB-	49413
@VP	to be a major determinant of reduced cavity size	49530
@VP	be a major determinant of reduced cavity size	49533
@VP	survive	49724
@VP	may have similar interactions with astrocytes -LRB- Fig. 3 -RRB-	50069
@VP	have similar interactions with astrocytes -LRB- Fig. 3 -RRB-	50073
@VP	received transplants directly into the lesion site	50183
@VP	either enhances astrocyte division	50293
@VP	exacerbates astrocytic hypertrophy -LRB- Fig. 3 -RRB-	50335
@VP	requires long-term survival of OECs	50616
@VP	caused by unfavorable OEC -- astrocyte interactions	50688
@VP	were detected within the lesion site of rostrocaudally	50930
@VP	detected within the lesion site of rostrocaudally	50935
@VP	arguing that the immune response may contribute to , but is not responsible for	51044
@VP	may contribute to , but is not responsible for	51077
@VP	may contribute to	51077
@VP	contribute to	51081
@VP	is not responsible for	51100
@VP	increased astrogliosis in directly transplanted animals	51124
@VP	promotes OEC survival	51397
@VP	reduce astrogliosis	51476
@VP	allowing SC infiltration and axonal extension	51538
@VP	could contribute to or potentiate regeneration regardless of OEC type	51745
@VP	contribute to or potentiate regeneration regardless of OEC type	51751
@VP	contribute to	51751
@VP	potentiate regeneration regardless of OEC type	51768
@VP	performed after OB OEC transplantation	51848
@VP	would be similarly beneficial	52056
@VP	be similarly beneficial	52062
@VP	affect axonal sprouting	52309
@VP	sprouting	52323
@VP	was effective at drawing axons toward the lesion boundaries	52571
@VP	drawing axons toward the lesion boundaries	52588
@VP	were able to penetrate the lesion/host interface	52644
@VP	to penetrate the lesion/host interface	52654
@VP	penetrate the lesion/host interface	52657
@VP	decreased GFAP reactivity and cavity formation -LRB- Fig. 3 -RRB-	52870
@VP	may be maximized by rostrocaudal	52981
@VP	be maximized by rostrocaudal	52985
@VP	maximized by rostrocaudal	52988
@VP	decreased by direct , LP OEC transplantation	53019
@VP	transplanted rostrocaudally than directly with OB OECs	53273
@VP	are present within the lesion in LP-treated rats -LRB- Fig. 5 -RRB-	53541
@VP	suggests that LP and OB OECs might secrete different neurotrophic factors	53605
@VP	might secrete different neurotrophic factors	53634
@VP	secrete different neurotrophic factors	53640
@VP	secrete them at different levels	53686
@VP	are not understood	53918
@VP	understood	53926
@VP	may be affected	54017
@VP	be affected	54021
@VP	affected	54024
@VP	facilitating differential growth of different axonal populations	54141
@VP	altering local circuitry	54227
@VP	may be induced by LP versus OB OECs , which could result in undesired effects	54325
@VP	be induced by LP versus OB OECs , which could result in undesired effects	54329
@VP	induced by LP versus OB OECs , which could result in undesired effects	54332
@VP	could result in undesired effects	54368
@VP	result in undesired effects	54374
@VP	sprouting of some axonal populations	54660
@VP	secrete different neurotrophic factors	54733
@VP	therefore may differently promote recovery -LRB- Fig. 8 -RRB-	54776
@VP	promote recovery -LRB- Fig. 8 -RRB-	54802
@VP	sprouted significantly more in OB - than LP-treated rats -LRB- Fig. 8 -RRB-	54841
@VP	sprouting	54946
@VP	was highly promoted by LP OEC transplantation -LRB- Fig. 8 -RRB-	55000
@VP	promoted by LP OEC transplantation -LRB- Fig. 8 -RRB-	55011
@VP	to promote axon elongation	55103
@VP	promote axon elongation	55106
@VP	are in accord with their roles in the olfactory neuraxis	55130
@VP	directly comparing LP and OB OEC transplantation in a single SCI model	55705
@VP	are retained after they are transplanted into lesioned spinal cord	55857
@VP	retained after they are transplanted into lesioned spinal cord	55861
@VP	are transplanted into lesioned spinal cord	55881
@VP	transplanted into lesioned spinal cord	55885
@VP	was achieved with rostrocaudal LP OEC transplantation	56195
@VP	achieved with rostrocaudal LP OEC transplantation	56199
@VP	is also associated with autotomy	56255
@VP	associated with autotomy	56263
@VP	sprouting associated with rostrocaudal LP OEC transplantation	56321
@VP	associated with rostrocaudal LP OEC transplantation	56331
@VP	be controlled so that appropriate connections are favored over inappropriate	56388
@VP	controlled so that appropriate connections are favored over inappropriate	56391
@VP	are favored over inappropriate	56434
@VP	favored over inappropriate	56438
@VP	are not adversely affected	56494
@VP	adversely affected	56502
@VP	promote regeneration	56601
@VP	combined with directed axon guidance stimulation	56687
@VP	to restore motor and sensory function after spinal cord lesion	56781
@VP	restore motor and sensory function after spinal cord lesion	56784
